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ABSTRACT
Cardiorespiratory fitness (CRF) is well established as having a strong inverse 
association with numerous cardiovascular disease (CVD) risk factors and mortality. As 
CVD remains the number one cause of death in America, the detrimental effects of low 
CRF present a substantial health threat. The studies presented in this dissertation 
syndicate both epidemiologic and clinical data that will enrich the knowledge base 
regarding the magnitude of change in CRF in relation to CVD risk factors.  
Recently, the American Heart Association established a new construct termed 
ideal cardiovascular health (CVH), which is characterized by seven metrics known as 
Life’s Simple 7. The concept emphasizes seven positive health factors and behaviors. 
The promotion of achieving and retaining these metrics at an ideal level serves to 
improve CVH and decrease public health burden and CVD mortality. This first study of 
this dissertation found that higher levels of CRF are strongly associated with better CVH 
profiles, which was demonstrated by individuals with moderate and high CRF exhibiting 
almost 11 and 40 times greater odds of having average or optimum CVH scores, 
respectively, compared to low fit individuals. Additionally, longitudinal analyses showed 
that improvements in CRF over time are associated with significant improvements in 
CVH score. These findings support the vital role CRF plays in public health efforts 
aiming to prevent the development of CVD and reduce CVD mortality risk. 
Secondly, this dissertation investigated the responsiveness of CRF, as measured 
by maximal oxygen consumption (V̇O2max), and CVD risk factors following aerobic 
exercise intervention. Aerobic exercise interventions are used to increase CRF in order 
to help combat the detrimental effects of low CRF. However, relying solely upon group 
vi 
mean changes can be misleading as considerable inter-individual variation exists in the 
ability to improve CRF and CVD risk factors to standardized interventions. This study is 
likely the first assess the prevalence of V̇O2max responsiveness across 14 diverse 
exercise interventions. Although the exercise interventions produced significant mean 
increases in V̇O2max, evaluation of individual changes in V̇O2max revealed that 34% of the 
total sample was considered low V̇O2max responsive. Within studies that employed 
multiple exercise interventions, a trend emerged. As exercise amount and intensity 
increased within studies, prevalence of low V̇O2max response decreased. The utility of 
these responsiveness cutpoints helps to provide a better understanding of the inter-
individual variation in response to exercise training to enhance our ability to provide 
personalized exercise prescription for improved health and attenuated CVD risk.  
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Cardiorespiratory fitness (CRF) is well established as having a strong 
inverse association with numerous cardiovascular disease (CVD) risk factors and 
mortality.1 As CVD remains the number one cause of death in America,2 the 
detrimental effects of low CRF present a substantial health threat. Recently, the 
American Heart Association (AHA) launched a new primordial prevention 
approach called, “Life’s Simple 7” which emphasizes seven positive health 
factors and behaviors [blood cholesterol, blood pressure (BP), fasting plasma 
glucose, diet quality, physical activity (PA), smoking, and body mass index 
(BMI)]. The promotion of achieving and retaining these health metrics at an ideal 
level serves to improve cardiovascular health (CVH) and decrease public health 
burden and CVD mortality in the United States (U.S.).3 Despite the strong 
associations between CRF and each individual component of “Life’s Simple 7,” 
the associations between CRF and ideal CVH in adults cross-sectionally or 
longitudinally are currently unknown. 
Aerobic exercise interventions are used to increase CRF, as measured by 
maximal oxygen uptake (V̇O2max), as an experimental approach in order to help 
combat the detrimental effects of low CRF. However, considerable inter-
individual variation exists in the ability to improve CRF and CVD risk factors in 
response to regular exercise. Given the strong relationship between V̇O2max and 
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cardiometabolic risk factors, identifying individuals who may not experience 
clinically significant gains in CRF with aerobic training (i.e., low V̇O2max response) 
is of great interest. The ability to identify individuals who respond unfavorably to 
an exercise intervention will facilitate adjustment of their exercise prescription to 
maximize clinically important health adaptations.  
The studies of this dissertation syndicated both epidemiologic and clinical 
data to enrich the knowledge base regarding the magnitude of change in CRF 
and cardiovascular health markers. The relationship between changes in CRF 
and changes in ideal CVH profile were established by analyzing data from a 
large prospective, longitudinal study. Then, data from eight large exercise 
training studies comprised of 14 different standardized exercise interventions 
was utilized to assess the prevalence of low V̇O2max response and determine if 
V̇O2max responsiveness is related to concomitant changes in cardiometabolic risk 
factors. Thus, the purpose of these studies was to 1) identify the relationship 
between ideal cardiovascular health and CRF both cross-sectionally and 
longitudinally, 2) ascertain the prevalence of low V̇O2max response across several 
standardized aerobic exercise interventions, and 3) identify the relationship 
between V̇O2max responsiveness and changes in CVD risk factors across the 
aforementioned exercise interventions. The following aims were proposed to 
accomplish these goals.   
Aim 1 evaluated whether ideal CVH as defined by AHA’s ‘Life’s Simple Seven’ is 
associated with CRF. In addition, the relationship between changes in CRF and 
changes in ideal CVH score over time was examined. These associations were 
3 
investigated in the Aerobics Center Longitudinal Study (ACLS), a prospective 
observational study where the participants underwent thorough medical 
examinations and maximal graded exercise testing to assess CRF at multiple 
time points. CRF as a continuous variable was quantified as treadmill time (mins) 
achieved during graded maximal exercise testing. Additionally, three CRF groups 
were created from age- and sex-specific quintiles based on previously 
established cutpoints of treadmill time: low (lowest 20%), moderate (middle 
40%), and high CRF (upper 40%). For longitudinal analyses, change in CRF was 
categorized by grouping participants into categories of loss, stable, or gain, 
based on tertiles of change in CRF. The ideal CVH metrics comprising ‘Life’s 
Simple Seven’ were used to create an ideal CVH score for participants in the 
ACLS. These metrics include seven positive health factors and behaviors: 
abstinence from smoking within the past year, ideal body mass index, physical 
activity at goal levels, consumption of a dietary pattern that promotes 
cardiovascular health, untreated total cholesterol (< 200 mg/dL), untreated blood 
pressure (<120/80 mmHg), and the absence of diabetes mellitus and clinical 
CVD. Each of these ideal CVH metrics was classified as poor (value of 0), 
intermediate (1) or ideal (2). Ideal CVH was calculated by summing the scores 
across all seven categories, with each poor metric receiving no points, each 
intermediate metric receiving one point, and each ideal metric receiving two 
points.  Participants were categorized based on their total ideal CVH score out of 
14 possible points as follows: inadequate (0-4), average (5-9), and optimum (10-
14). Change in total ideal CVH score was categorized by grouping participants 
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into categories of loss, stable, or gain, based on tertiles of change for longitudinal 
investigations. This study will provide valuable insight as to whether ideal CVH is 
associated with CRF and whether improvements in CRF over time are 
associated with beneficial changes in ideal CVH score.  
Objective 1.1: To determine the cross-sectional association of ideal CVH 
with CRF 
Hypothesis 1.1: We hypothesized that higher CRF, as a continuous 
variable, will be correlated with greater ideal CVH score. We also 
hypothesized that participants in the moderate to high categories of CRF 
will have increased odds for being in average or higher ideal CVH 
categories. 
Objective 1.2: To examine the longitudinal association of changes in CRF 
with changes ideal CVH score 
Hypothesis 1.2: We hypothesized that increases in CRF over time are 
associated with beneficial changes in ideal CVH score.  
Aim 2 sought to identify cutpoints in order to define low V̇O2max responsiveness. 
Using these cutpoints, prevalence of low V̇O2max response across eight large 
exercise training studies that include 14 different standardized and supervised 
aerobic exercise interventions was assessed. Subsequently, Aim 2 investigated 
the relationship between changes in V̇O2max and changes in cardiometabolic risk 
factors. Participants were enrolled in one of 14 exercise training programs that 
ranged from doses of 4-35 kcal·kg-1·week-1 (KKW); intensities of 50-85% V̇O2max; 
and durations of 20-35 weeks. Baseline and post-training V̇O2max assessments 
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were completed via maximal graded exercise testing. Low V̇O2max response was 
defined in both absolute and relative terms based on technical error (TE) and 
coefficient of variation values derived from three repeatability studies in the 
HERITAGE Study. Results from this aim determined the association between 
V̇O2max responsiveness and concomitant changes in cardiometabolic risk factors 
[resting systolic blood pressure (SBP) and fasting insulin, high-density lipoprotein 
cholesterol (HDL-C), and triglycerides (TG)]. This enhanced understanding will 
improve the ability to develop and adjust future exercise programming. 
Objective 2.1: To identify cutpoints to define responsiveness of change in 
V̇O2max following standardized aerobic exercise interventions 
Objective 2.2: To determine the prevalence of low V̇O2max response 
across multiple standardized aerobic exercise interventions 
Objective 2.3: To examine whether exercise dose and/or intensity is 
associated with the prevalence of low V̇O2max response 
Hypothesis 2.3: We hypothesized that greater exercise dose and 
intensity will yield lower prevalence of low V̇O2max response, with intensity 
playing a larger role in V̇O2max responsiveness. 
Objective 2.4: To compare differences in changes of cardiometabolic risk 
factors between V̇O2max response groups 
Hypothesis 2.4: V̇O2max responders will have greater beneficial changes 
in cardiometabolic risk factors compared to low V̇O2max responders.  
Objective 2.5: To determine the distribution of low responses across all 
traits (CRF, resting SBP, fasting insulin, HDL-C, and TG) 
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Hypothesis 2.5: There will be participants with one or more low 
responses, however we hypothesize that no individual will be a low 
responder for all traits. 
These studies are likely the first to evaluate the relationship between CRF 
and the AHA’s ideal CVH score in adults. In addition, we will be one of the first to 
examine whether improving CRF relates to a positive change in ideal CVH score 
over time. Recent investigations have found that increasing numbers of ideal 
CVH metrics and scores are associated with more favorable future CVD 
outcomes.4-16 Thus, our study’s examination of CRF’s association with increasing 
ideal CVH score will provide meaningful insight for future investigations regarding 
CRF’s role in public health efforts aiming to prevent the development of CVD.  
We will also likely be the first to establish cutpoints to define V̇O2max 
responsiveness by using a comprehensive and data-driven approach that is 
based on repeatability studies conducted in the HERITAGE study. Our innovative 
study design employed a large sample size that included multiple standardized 
and supervised aerobic exercise interventions. To date, no other study has 
evaluated the prevalence of low V̇O2max response across diverse populations and 
varying exercise programs. As we move further into the era of personalized 
medicine, a better understanding of the inter-individual variation in response to 
exercise training will enhance our ability to utilize exercise as medicine and 
provide appropriate guidance to improve health and attenuate risk for 





 Aim 1 evaluated if ideal cardiovascular health (CVH) as defined by the 
AHA’s “Life’s Simple Seven”3 is associated with CRF (Objective 1.1). In addition, 
the relationship between changes in CRF and changes in ideal CVH score over 
time was examined (Objective 1.2). 
Study Design 
 This study employed both cross-sectional and longitudinal analyses. A 
cross-sectional analysis examined if CRF is associated with ideal CVH. A 
longitudinal analysis was used to examine the relationship between changes in 
CRF and changes in ideal CVH score over time.  
To address aim 1, data from the ACLS was utilized. The ACLS is a 
prospective observational study of participants who were self-, employer-, or 
physician-referred for an extensive medical examination at the Cooper Clinic in 
Dallas, Texas. The study investigated the health outcomes associated with 
physical activity and CRF levels. All participants received written and oral 
informed consent and the ACLS study has been reviewed and approved annually 




This study included participants from the ACLS who completed at least 
two medical examinations by a physician after a 12-hour (hr) overnight fast 
between the years of 1987-1999. The medical examination was a complete 
preventive medical evaluation including physical examination, personal and 
family health history, questionnaires (demographics and health habits), 
anthropometry, resting electrocardiography, blood chemistry analyses, blood 
pressure, and a maximal exercise treadmill test. Health history questionnaires 
included: personal history of myocardial infarction, stroke, hypertension, 
diabetes, and cancer; parental history of CVD; smoking status, alcohol intake, 
and PA. Participants also completed a 3-day diet recall. Time between 
examinations ranged from 12 months to 11 years. Details of the examinations 
have been described elsewhere.17 Participants with complete data on CRF and 
all of the AHA’s “Life’s simple 7”3 health behaviors and factors (smoking, BMI, 
PA, dietary data, blood cholesterol, blood pressure, and fasting plasma glucose) 
were included. Participants were excluded if they had any form of CVD or cancer, 
or if they had abnormal findings on electrocardiography at baseline.  
Measurements 
Anthropometrics. Anthropometric measures were taken and BMI was 
calculated as weight in kilograms divided by height in meters squared. BMI 
values were classified as follows: normal (18.5-24.9 kg/m2), overweight (25.0-
29.9 kg/m2), or obese (≥30.0 kg/m2). Resting blood pressure was measured by 
the auscultatory method with a mercury sphygmomanometer. To ensure 
!
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accuracy, two measures were taken and if the readings differed by more than 5 
mmHg, then a third measure was taken and all the measures were averaged. 
Blood samples were taken from the antecubital vein after 15 to 20 minutes (min) 
of sitting. Concentrations of total cholesterol and fasting plasma glucose were 
measured by automated techniques.18-20  
Cardiorespiratory fitness. Maximal treadmill testing using a modified 
Balke protocol was used to assess CRF, which was defined as treadmill time in 
min, at baseline and during follow-up visits, as previously described.17, 21 Three 
CRF groups were created from age- and sex-specific quintiles based on the 
previously established cutpoints of treadmill time: low (lowest 20%), moderate 
(middle 40%), and high (upper 40%) CRF.17 
Change in CRF as a continuous variable was calculated as the difference 
in treadmill time between the first two adjunct examinations and divided by the 
number of years between them. Annual change in CRF was used to define 
change in fitness because the intervals between the follow-up examinations 
varied among individuals in our cohort. Annual change in CRF was categorized 
by grouping participants into categories of loss, stable, or gain, based on tertiles 
of change in CRF. For example, a participant categorized in the low CRF group 
at baseline and increased to the moderate CRF group at follow-up would be 
categorized as gain in the CRF change groups. 
Diet. Participants were asked to keep detailed records of everything they 
consumed over two pre-assigned weekdays and one weekend day for the 3-day 
dietary assessment. Written instructions on how to accurately describe foods and 
!
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portion sizes were given to each participant. Registered dietitians at the Cooper 
Clinic coded and analyzed the diet records using the Cooper Clinic Nutrition and 
Exercise Evaluation system. Achievement of the AHA diet goals were 
categorized as follows: 4.5 or more servings of fruits and vegetables per day, two 
or more 3.5 oz. servings per week of fish, shellfish, or other seafood, three or 
more servings per day of whole grains, and less than 1500 mg per day of 
sodium. Diet scores were assigned by giving a point for each diet goal met (i.e., 
consuming <1500 mg/day of sodium is one point) for a total possible score of 
four points.  
Physical Activity. Participants completed a formerly validated 
questionnaire to assess leisure time PA over the past three months, which 
included type, frequency, and duration of activity. PA categories were created 
based on the responses to 10 specific activities: walking, jogging, running, 
treadmill exercise, cycling, stationary cycling, swimming, racquet sports, aerobic 
dance, and other sports related activities. The intensity of the activities was 
estimated using speed-specific or activity-specific MET values from the 
Compendium of Physical Activities.22 MET-min per week (min/wk) were then 
calculated by multiplying the MET value for each activity by frequency and 
duration. Then, MET-min/wk for all activities was added together. For the present 
study, participants were classified into three categories based on the 2008 
Physical Activity Guidelines for Americans:23 inactive (0 MET-min/wk), insufficient 
(1-499 MET-min/wk), and recommended (≥500 MET-min/wk).  
!
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AHA Ideal Cardiovascular Health. Ideal CVH was determined by 
assessing the presence of seven positive health factors and behaviors that 
include: abstinence from smoking within the past year, ideal body mass index, 
physical activity at goal levels, consumption of a dietary pattern that promotes 
cardiovascular health, untreated total cholesterol (<200 mg/dL), untreated blood 
pressure (<120/80 mmHg), and the absence of diabetes mellitus and clinical 
CVD.3 Each of these ideal CVH metrics will be classified as poor (value of 0), 
intermediate (1) or ideal (2). Ideal CVH was calculated by summing the scores 
across all seven categories, with each poor metric receiving no points, each 
intermediate metric receiving one point, and each ideal metric receiving two 
points.  Participants’ were categorized based on their total ideal CVH score out of 
14 possible points as follows: inadequate (0-4 points), average (5-9 points), and 
optimum (10-14 points).  
Change in total ideal CVH score as a discrete variable was calculated as 
the difference in total ideal CVH score between the first two adjunct 
examinations, and divided by the number of years between them. Change in total 
ideal CVH score was categorized by grouping participants into categories of loss, 
stable, or gain, based on tertiles of change as described above for change in 
CRF categories.  
Data Analysis 
Baseline characteristics were summarized for the total population and by 
sex. Differences between sexes at baseline were determined by t-tests for 
continuous variables and chi-square tests for categorical variables. Multivariable 
!
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general linear and logistic regression models were used to evaluate the 
association of baseline CRF with baseline ideal CVH score and to estimate the 
odds of being in the average or optimum ideal CVH categories by baseline CRF 
categories, respectively. These cross-sectional analyses controlled for age, sex, 
and year of examination.  
To investigate the longitudinal association between changes in CRF and 
changes in ideal CVH, we employed linear regression models adjusting for age, 
sex, and time between exam dates. Separate models that included CRF and 
ideal CVH as either continuous or categorical variables were used. All models 
were performed in the total population and stratified by sex (removing sex as 
covariate in model).  
SAS version 9.4 was used for all statistical analyses. The threshold for 
statistical significance was set at the p<0.05 level. 
Aim 2 
 Aim 2 established cutpoints in order to define responsiveness for change 
in V̇O2max following standardized aerobic exercise interventions (Objective 2.1). 
Using this definition, assessment of the prevalence of low V̇O2max response 
across 14 large, standardized aerobic exercise interventions was completed 
(Objective 2.2). Furthermore, aim 2 examined whether exercise dose, intensity, 
and/or program duration is associated with the prevalence of low V̇O2max 
response (Objective 2.3). Subsequently, Aim 2 investigated the relationship 
between changes in V̇O2max and changes in cardiometabolic risk factors (resting 
SBP and fasting plasma insulin, HDL-C, and TG) utilizing these 14 aerobic 
!
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exercise interventions. This aim compared the difference of changes in 
cardiometabolic risk factors between V̇O2max response groups (Objective 2.4). 
Additionally, this aim explored the distribution of low responses across all traits 
via a total risk factor response score (Objective 2.5). 
Study Design 
 This study employed both cross-sectional and longitudinal designs to 
analyze data from previously completed experimental trials. A longitudinal design 
was used to determine participants’ change in V̇O2max from baseline to post 
aerobic exercise intervention. Two cutpoints were applied to the V̇O2max change 
scores in order to define low V̇O2max response in both absolute and relative 
terms. Subsequently, these created categories of V̇O2max responsiveness were 
used in a cross-sectional analysis in order to determine the prevalence of low 
V̇O2max response for each intervention and determine if V̇O2max responsiveness is 
related to concomitant changes in cardiometabolic risk factors. To address aim 2, 
data from 14 completed aerobic exercise interventions from eight of the largest 
exercise training studies was utilized.  
Study Population 
The present study examined data from 14 distinct supervised exercise 
interventions (n=1,724) from the following completed exercise training studies: 
Health, Risk Factors, Exercise Training And Genetics Family Study (HERITAGE), 
Dose-Response to Exercise in Women (DREW), Gene Exercise Research Study 
(GERS), Energy Flux, Examination of Mechanisms of Exercise-induced Weight 
Compensation (E- MECHANIC), Inflammation and Exercise (INFLAME), and 
!
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Studies of a Targeted Risk Reduction Intervention through Defined Exercise 
(STRRIDE) I and II. These interventions provide a diverse array of populations, 
standardized exercise programs, and baseline fitness levels. Overall, these 
exercise interventions ranged from doses of 4-35 kcal·kg-1·week-1 (KKW); 
intensities of 50-85% V̇O2max; and durations of 20-35 weeks. All participants from 
these exercise training studies received written and oral informed consent. The 
studies were all reviewed and approved by each institution’s Institutional Review 
Board. 
Exercise Training Study Protocols 
DREW. The DREW Study was a randomized controlled dose-response 
exercise trial. The present study sample will include 361 previously sedentary, 
postmenopausal women (63% White) with a BMI of 25-40 kg/m2, resting systolic 
blood pressure of 120-159 mmHg, and resting diastolic blood pressure ≤99 
mmHg who completed one of three 24-week aerobic exercise programs. The 
three exercise programs expended 4 (n=155), 8 (n=104), or 12 (n=102) kcal per 
kg of body weight per week (KKW). All participants alternated training sessions 
on a cycle ergometer or treadmill with a target intensity of 50% V̇O2max. Exercise 
training sessions were completed three to four times per week.24  
GERS. The GERS sample will include 171 previously sedentary, non-
diabetic, non-smoking men and women (56%) aged 50-71 years (73% White). 
Participants had no history of CVD, were normotensive or had medication-
controlled blood pressure, and had a BMI <37 kg/m2. The exercise training 
program consisted of 24 weeks (three sessions per week) of aerobic exercise. 
!
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Participants used various types of aerobic exercise equipment including cycle 
ergometers, treadmills, rowers, and elliptical, skier, and stepping machines.25 
Exercise training progressed to a target exercise intensity of 70% V̇O2max.26, 27 
HERITAGE. The HERITAGE sample included 718 (66% White) men and 
women (56%) aged 17-65 years who completed a 20-week endurance exercise 
program. Participants were sedentary at baseline, normotensive to untreated 
mildly hypertensive (<160/100), and body mass index (BMI) was less than 40.0 
kg/m2. The exercise program consisted of aerobic exercise performed three days 
per week on a cycle ergometer. Training progressed to a target exercise intensity 
of 75% V̇O2max.28  
Energy Flux. The Energy Flux Study was a randomized controlled 
exercise trial. The present study sample will include 65 men and women (46%) 
aged 21-45 years (48% White) who completed one of two 24-week aerobic 
exercise interventions. Participants were previously sedentary, generally healthy 
adults with a BMI of 25-35 kg/m2. The two exercise intervention programs 
expended 17.5 (n=33) or 35 (n=32) KKW. Training progressed to target exercise 
intensity 70-75% maximal heart rate (HR) (based on most recent maximal 
exercise test). All exercise was performed on a treadmill 3-6 times per week.  
INFLAME. The INFLAME sample will include 66 previously sedentary, 
generally healthy, non-smoking men and women (65%) who completed a 16-
week aerobic exercise intervention. Participants (65% White) were aged 30-75 
years with a BMI 18-40 kg/m2, blood pressure <140/90 mmHg, and elevated 
plasma C-Reactive Protein concentration (≥2.0 mg/L but <10.0 mg/L) at baseline. 
!
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Exercise training expended 16 KKW at a target exercise intensity 60-80% 
V̇O2max. Exercise was performed on either a treadmill or cycle ergometer 3-5 
times per week.29  
E-MECHANIC. E-MECHANIC was a six-month randomized controlled 
exercise trial. The sample to be used for the present study includes 117 men and 
women (72%) who completed one of two aerobic exercise interventions. 
Participants (68% White) were non-smoking, generally healthy, previously 
sedentary adults (aged 18-65 years) with a BMI of 25-45 kg/m2. The two exercise 
groups expended 8 (n=60) or 20 (n=57) KKW for 24 weeks. All exercise was 
performed on a treadmill at a target intensity of 65-85% V̇O2max. Exercise 
sessions were completed 3-5 times per week.30 
STRRIDE. The STRRIDE I and II studies were randomized controlled 
exercise trials lasting for eight months. The present study sample includes 227 
(83% White) non-smoking men and women (50%) who completed one of four 
exercise training interventions. Participants were free of diabetes and coronary 
artery disease, aged 40-65 years with a BMI 25-35 kg/m2, resting blood pressure 
<160/90 mmHg, and mild-to-moderate dyslipidemia [low-density lipoprotein 
cholesterol (LDL-C) 130-190 mg/dL and/or HDL-C 40mg/dL (men) or 45 mg/dL 
(women)]. Combining STRRIDE I and II, participants completed one of four 
exercise interventions: mild (14 KKW; 40-55% V̇O2peak; n=36), moderate (14 
KKW; 65-80% V̇O2peak; n=90), high (23 KKW; 65-80% V̇O2peak; n=57), or 




8-12 repetitions per set; n=44). Aerobic exercise was performed three times per 
week on treadmills, elliptical machines, or cycle ergometers.31, 32 
Study-Specific Measurements 
DREW. Full details of the DREW study design and methods are available 
elsewhere.24 The DREW Study participants completed laboratory and self-report 
measures at baseline and six months. Measures included: V̇O2max, resting BP, 
anthropometry, dietary habits, PA history, medication use, menstrual history, 
personal and family medical history, and fasting cholesterol, TG, and glucose. 
V̇O2max was assessed via two maximal cycle ergometer tests on separate days at 
baseline and follow-up. Participants practiced on the cycle ergometer during the 
initial baseline medical assessment. Prior to exercise testing, resting 
electrocardiography (ECG), heart rate (HR), and BP were measured. Participants 
exercised at 30 Watts (W) for 2 min, 50 W for 4 min, followed by increases of 20 
W every 2 min until exhaustion. Throughout the test, BP, HR, ECG, V̇O2, carbon 
dioxide (CO2) production, ventilation and respiratory exchange ratio (RER) were 
measured. Respiratory gases were measured using a ParvoMedics True Max 
2400 metabolic measurement cart (Sandy, UT). Two fitness tests were 
performed on separate days at baseline and follow-up. The average V̇O2max from 
these two tests was used as V̇O2max. 
 Following a 30-min recumbent rest period, at least four BP measurements 
were taken using an automated BP unit (Colin STBP-780). Each BP 
measurement was separated by two min.  
!
18 
 At baseline and follow-up, blood samples were obtained via an antecubital 
vein following a 10-12 hr fast. Fasting blood glucose concentration and blood 
lipid profiles were determined with a Dimension RXL analyzer (Oxford, CT). 
Additionally, plasma insulin was measured by electrochemiluminescence.  
GERS. Full details of the GERS study design and methods are available 
elsewhere.26, 27 Study measurements included medical history, fasting blood 
samples (genotyping and plasma lipids), glucose tolerance testing, physical and 
cardiovascular examination by a physician, and maximal exercise testing at 
baseline and post-training. V̇O2max was assessed via Bruce maximal treadmill 
exercise testing.33 HR, BP, and ECG results were recorded prior to the start of 
the test, at the end of each exercise stage, and after completion of the test. V̇O2 
was measured continuously and directly throughout the test using a customized 
metabolic system (Marquette Respiratory Mass Spectrometer, Rayfield Mixing 
Chamber, VMM Ventilatory Turbine).  
 Participants were fasted and sat quietly in the laboratory for 15 min prior to 
resting BP measurements were obtained. BP was measured while the 
participants were seated with their arm at heart level. Two measurement values 
had to agree within ± 5 mmHg. Averages from two days of BP measures were 
used to determine resting BP. 
 Blood samples were obtained in the morning following an overnight fast. 
For plasma lipid levels, blood samples were taken on two separate days and 
averaged. At least three days before exercise training began, blood samples 
were drawn after the completion of the 6-wk dietary stabilization period. Post-
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training samples were obtained 24-36 hr after the participant’s final exercise 
training session. Plasma insulin levels were determined via radioimmunoassay 
(Linco Research, St. Charles, MO). Plasma HDL-C levels were measured after 
precipitation with dextran sulfate on a CDC-certified Hitachi 717 analyzer. 
HERITAGE. Full details of the HERITAGE study design and methods are 
reported elsewhere.28 Participant measures included: blood samples (plasma 
lipids, glucose, insulin, sex steroids, glucocorticoids), body fat and fat distribution, 
dietary and activity habits (questionnaires), several genetic analyses, and two 
maximal exercise tests at baseline and follow-up. These two tests were 
conducted at approximately the same time of day with at least 48 hrs between 
the two tests. All maximal exercise tests were performed on a cycle ergometer 
and included the following measures: ventilatory rate (V̇E), V̇O2, volume of carbon 
dioxide expired (V̇CO2), RER, BP, HR, cardiac output, stroke volume, and blood 
variables (glucose, free-fatty acids, lactate, and total proteins).  
Respiratory gases were measured by using a SensorMedics 2900 metabolic cart.  
The average V̇O2max from the two tests was calculated and recorded as V̇O2max 
for each subject given that both values were within 5% of each other. If V̇O2max 
from the two tests differed by more than 5%, the higher V̇O2max value was used.  
 Following a 5-min rest period, resting BP was measured using an 
automated blood pressure unit (Colin STBP-780; San Antonio, TX). At 2-min 
intervals, four readings were taken. Resting BP was recorded as the mean of 
three or more reliable measurements.  
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 Blood samples were obtained from venipuncture of an antecubital vein 
into vacutainer tubes containing EDTA. Blood draws were performed in the 
morning following a 12-hr fast. Blood samples were collected twice at baseline on 
separate days. Post-training blood samples were taken at 24 and 72 hr after the 
final training session. Samples were obtained early in the follicular phase of the 
menstrual cycle for eumenorrheic women. Total cholesterol and TG levels were 
determined in plasma and lipoproteins by enzymatic methods (Technicon RA-
500 Analyzer; Bayer Corporation Inc., Tarrytown, NY). HDL-C fractions were 
obtained after precipitation of LDL in the infranatant via the heparin manganese 
chloride method. Fasting plasma insulin samples were obtained at baseline as 
well as one and three days after the final exercise bout. Plasma insulin (i.e., 
immunoreactive insulin) was measured by radioimmunoassay following 
polyethylene glycol separation.  
Energy Flux. Full details of the Energy Flux Study design and methods 
are in submission. Measurements of body composition, energy expenditure, 
resting metabolic rate, peak oxygen consumption (V̇O2peak), dietary intake (four 
day diet recall), blood chemistry (glucose, leptin, grehlin, C-reactive protein, 
apolipoprotein B, β-hydroxybutyrate, a lipid panel), and several questionnaires 
regarding health behavior, current mood status, and overall health were 
completed at baseline, three and six months. V̇O2peak was assessed on a 
treadmill using a modified Bruce protocol with ECG. This exercise test consisted 
of two-minute stages in which the participants worked to volitional fatigue, as 
previously described.34 BP, HR, and rating of perceived exertion (RPE) were 
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recorded during the last 30 seconds (s) of each stage. Expired gases were 
collected continuously via a stationary metabolic system (True One 2400, 
ParvoMedics, Sandy, UT) to determine V̇O2peak. Participants in both exercise 
groups performed a second fitness test at the end of the four-week run-in period 
to adjust exercise intensity due to potential acute training adaptations.  
 Resting BP was measured using a sphygmomanometer and stethoscope 
while the participant was sitting quietly. At least two measurements were taken to 
be within 10 mmHg for systolic BP and within 5 mmHg for diastolic BP. The 
average of the measurements was recorded as resting BP.  
 Following a 12-hr fast and 24-hr abstention from physical activity, blood 
samples were obtained at baseline, 3-months, and 6-months (post-intervention). 
Blood samples were obtained from an antecubital vein into tubes containing 
EDTA. Samples were stored at -80°C and sent in entirety to LabCorp (Columbia, 
SC) for fasting HDL-C, TG, and insulin analysis upon completion of the study. 
INFLAME. Full details of the INFLAME design and methods can be 
obtained elsewhere.29 Study measurements were completed at baseline and 
post-training and included the following: anthropometrics, blood chemistry (C-
reactive protein, lipids, fasting glucose, and insulin), BP, CRF, and energy intake. 
Fitness testing was performed on a cycle ergometer with ECG. Participants 
cycled at 30 W for 2 min, 50 W for 4 min, and subsequent increases of 20 W 
every 2 min until participants could no longer maintain a pedal cadence of 50 
rpm. Throughout the test, HR, RPE, V̇O2, CO2 production, ventilation, and RER 
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were recorded. Respiratory gases were measured using a ParvoMedics’ 
TrueOne 2400 (Sandy, UT) Metabolic Measurement Cart.35  
 At least four BP measurements were performed after a 30-min recumbent 
rest period using an automated blood pressure unit (Colin STBP-780). Each 
measurement was separated by 2 min. 
 Throughout the trial, blood samples were taken at three separate visits: 3 
ml at the orientation session, 20 ml at baseline (approximately two weeks later), 
and 20 ml at the 4-month follow-up assessment. Participants were fasted for 10-
12 hr for each of the blood samples. Additionally, participants refrained from 
consuming alcohol or exercising for 24 hr and acutely refrained from using 
aspirin or anti-inflammatory medications for 48 hr prior to blood samples being 
obtained. Plasma insulin was measured by electrochemiluminescence. Fasting 
blood glucose concentration and blood lipid profiles were measured with a 
Dimension RXL analyzer.  
E-MECHANIC. Details of the E-MECHANIC study design and methods 
are available elsewhere.30 Primary assessments for this study occurred at 
baseline and post-training (24 weeks), and also utilized a truncated assessment 
period at week 4 to identify potential short- term changes in outcome variables. 
Participant assessments included anthropometrics, body composition, energy 
metabolism, physical activity (including V̇O2max), and blood chemistry. V̇O2peak 
was determined by a graded treadmill exercise test. Treadmill speed began at 
2.4 mph on a level grade for two min. Treadmill speed and/or grade increased 
every two min until volitional fatigue was reached. Throughout the intervention, 
!
23 
caloric expenditure rate was measured during exercise training with a metabolic 
cart. At least two resting BP measurements were taken after the participant 
rested in a seated position for at least five min.  
STRRIDE. For the STRRIDE (i.e., STRRIDE I) and STRRIDE AT/RT (i.e., 
STRRIDE II) studies, full details of study design and methods are available 
elsewhere.31, 32, 36 Study measurements included anthropometrics, BP, blood 
chemistry (carbohydrate and lipid metabolism), food intake, Metabolic Syndrome 
z score, and cardiorespiratory fitness at baseline and post-training.31 Additionally 
in STRRIDE II, overall strength was measured.32 To assess V̇O2peak, maximal 
cardiopulmonary exercise tests with ECG and expired gas analysis were 
performed on a treadmill. Expired gases were measured using a ParvoMedics’ 
TrueMax 2400 Metabolic Cart  (Sandy, UT). The protocol consisted of 2-min 
stages, increasing the work rate by approximately 1 MET per stage. The V̇O2 for 
the last 40 s of each state were averaged to determine V̇O2peak. 
 For STRRIDE I, resting BP was measured in the standing position just 
prior to maximal exercise testing. For STRRIDE II, resting BP was taken every 20 
min during the last hr of the 3-hr intravenous glucose tolerance test (GTT). 
Values were averaged to obtain resting BP.  
 Fasted blood samples were taken at baseline and post-intervention 
approximately 30-min prior to the start of the GTT. In regards to post-
intervention, blood samples were obtained 16-24 hr after the final exercise 
training session. Blood samples were taken into EDTA tubes from an intravenous 
catheter in the antecubital area. In order to control for inter-technician and inter-
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assay variability, pre- and post-intervention plasma samples from the same 
subject were analyzed together. Fasting insulin was measured by immunoassay 
(Access Immunoassay System, Beckman Coulter, Fullerton, CA). Fasting HDL-C 
and TG concentrations were estimated with NMR spectroscopy (LipoScience, 
Raleigh, NC).  
Data Analysis 
In order to quantify low V̇O2max responsiveness, we applied the findings of 
Skinner et al.’s report regarding the reproducibility of V̇O2max measured from 
maximal exercise testing in HERITAGE to the additional aerobic exercise 
interventions.37 Based on technical error (TE) and coefficient of variation values 
derived from this study, low V̇O2max response was defined in both absolute (gain 
<120 ml/min from baseline value) and relative (gain <5% of study-specific 
baseline average V̇O2max) terms. Subsequently, the prevalence of low V̇O2max 
response across interventions was calculated based on both the absolute and 
relative definitions. We used within-study group comparisons to compare the 
relative low V̇O2max responsiveness within studies that employed multiple 
exercise interventions.  
Based on previous literature from HERITAGE,37-42 low response for each 
cardiometabolic trait following exercise training was defined as any change value 
beyond 1xTE in a direction indicating a worsening of the risk factor was 
considered a low response. Baseline characteristics were summarized for the 
total population and by study. Prevalence of low response for each trait was 
assessed on the basis of the number of participants who exceeded the 1xTE 
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calculations. For each of the cardiometabolic risk factors, a logistic regression 
was performed to compare the distribution of low response between V̇O2max 
response groups.  
A total response score for all of the cardiometabolic risk factors was 
calculated for each participant. Each risk factor classified as a low response 
received no points, while each risk factor classified as a response received one 
point. Thus, a participant that did not display any low responses would receive 
four total points for their cardiometabolic risk factor score. A Χ2 test was 
performed to compare the distribution of the total response score between 
V̇O2max (relative) response groups. SAS version 9.4 was used for all statistical 






CRF is defined as the ability of the circulatory, respiratory, and muscular 
systems to supply oxygen to the body in order to perform physical work. Since 
CRF integrates numerous systems in the body, CRF quantifies the functional 
capacity of an individual and reflects total body health. CRF can be measured 
directly via maximal exercise tests and is expressed as V̇O2max. Although less 
precise, estimated CRF can be easily derived from the peak work rate achieved 
on a treadmill or cycle ergometer. Estimated CRF is commonly expressed in 
terms of metabolic equivalents (METs; a multiple of the resting metabolic rate 
approximating 3.5 mL·kg−1·min−1).  
Cardiorespiratory fitness and mortality risk 
Whether estimated or measured directly, mounting evidence has 
developed over the past 30 years establishing a strong inverse relationship 
between CRF and risk for CVD and all-cause mortality.17, 43, 44 Additionally, low 
levels of CRF are associated with higher mortality rates attributable to several 
cancers, especially colon and breast cancers.45 Moreover, mortality risk is 
notably reduced as CRF improves.46 In a recent scientific statement from the 
AHA concerning the importance of assessing CRF as a clinical vital sign, Ross 
and colleagues47 highlighted several critical references that express CRF in the 
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terms of survival benefit per MET. Collectively, these studies showed that each 
1-MET increment in CRF, which is a small, relatively attainable increment in 
fitness, was associated with a 10-25% improvement in survival.47 Furthermore, 
mortality risk reduction has even been shown to decrease by as much as 30% in 
low fit individuals (peak MET level <5) with CVD who improved exercise capacity 
following cardiac rehabilitation participation.48   
Recently, Naci and Ioannidis published a network meta-analysis to 
compare the effectiveness of exercise and pharmaceutical drug intervention on 
mortality risk.49 This study included 16 meta-analyses (12 drug and four exercise) 
along with three additional recent exercise trials, which collectively totaled 305 
randomized controlled trials (n=339,274). This analysis examined the benefits of 
exercise on the secondary prevention of coronary heart disease, treatment of 
heart failure, diabetes prevention, and stroke rehabilitation. This study did not 
find a statistical difference between exercise and pharmaceutical interventions in 
terms of mortality benefits for secondary prevention of coronary heart disease 
and diabetes. The results also showed that exercise and physical activity 
interventions were actually more effective than pharmaceutical interventions for 
the secondary prevention of stroke mortality. The authors noted that evidence 
from randomized controlled trials regarding mortality benefits from exercise 
intervention is scarce, especially when compared to the pharmaceutical 
intervention evidence (only 57 out of 305 trials were exercise interventions). 
Despite this limitation in the evidence base, Naci and Ioannidis’s study suggests 
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that exercise and drug interventions are potentially similar in effectiveness for 
mortality benefits.49 
Cardiorespiratory fitness and cardiovascular disease risk 
Several recent studies have shown the prominent role that CRF plays as a 
predictor of adverse CVH outcomes (e.g., acute myocardial infarction, ischemic 
heart disease, and CVD mortality). Compared to traditional risk factors, such as 
hypertension (HTN), insulin resistance, lipid abnormalities, smoking, and obesity, 
low CRF is the strongest predictor of risk for adverse CVH outcomes, including 
mortality.50-58 Remarkably, CRF level is not solely a critical risk factor for CVD; 
CRF also plays an influential role as a moderator for traditional CVD risk factors.  
Hypertension 
Chronic HTN is a major risk factor for CVD. Among individuals who 
develop adverse CVH outcomes, HTN is the most common risk factor. As stated 
by the Joint National Committee on Prevention, Detection, Evaluation, and 
Treatment of High Blood Pressure, the direct relationship between CVD risk and 
blood pressure (BP) begins at 115/75 mmHg.59 For each increment of 20/10 
mmHg, CVD risk doubles.60  
In 1984, Blair and colleagues were the first to investigate the relationship 
between measured CRF and HTN incident.61 Participants were normotensive, 
predominantly white, well-educated men and women (n=6,039) from the Aerobics 
Center Longitudinal Study (ACLS). Participant follow-up ranged from one to 12 
years. Blair et al. found that low fit individuals had a 1.5 times increased risk for 
developing HTN compared to high fit individuals, even after controlling for age, 
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sex, body mass index, baseline BP, and follow-up interval. For low fit individuals 
that were also in the highest BP category at baseline, risk for developing HTN 
increased tenfold.61 These findings were confirmed by Sawada et al.62 in 3,305 
normotensive Japanese men that were followed for five years. After adjusting for 
age, body fat, baseline BP, and additional confounding variables, relative risk for 
the development of HTN was 1.9 times greater for the least fit group compared to 
the group with the highest fitness level.62 In 2003, Carnethon et al. looked at the 
relationship between CRF in young adulthood and the development of CVD risk 
factors in 2,478 participants from the Coronary Artery Risk Development in 
Young Adults (CARDIA) study. The authors reported that each one-minute 
decrease in maximal treadmill time performance was associated with a 19% 
higher 15-year risk of incident HTN among men and women after adjustment for 
age, sex, weight gain, and other confounding variables.63 In addition, a 
subsequent study from the ACLS examined the association between CRF and 
incident HTN exclusively in women who were normotensive at baseline. Results 
showed that for each 1-MET increment in maximal exercise treadmill test 
performance, there were 19% lower odds for developing HTN.64 
Lifestyle interventions, such as increased physical activity and weight loss, 
contribute significantly to successful BP control. These positive lifestyle 
modifications provide beneficial changes in BP with minimal side effects.65 
Several meta-analyses have reviewed numerous well-controlled aerobic exercise 
studies and have consistently documented significant reductions in resting BP 
following intervention.66-82 Thus, leading organizations around the world 
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recommend approaches that include regular physical activity to prevent and treat 
HTN.59, 83-86  
In 2013, Cornelissen and Smart published the largest meta-analysis to 
date on randomized controlled trials investigating the effects of exercise training 
on resting blood pressure (n=5,223; 3,401 exercisers and 1,822 sedentary 
controls).80 This study included exercise interventions of endurance (105 groups), 
dynamic resistance (29 groups), combined endurance and resistance training (14 
groups), and isometric resistance training (5 groups) in adults who ranged from 
normotensive to hypertensive. For the purpose of this literature review, 
discussion focuses on endurance exercise training. Overall, training duration 
ranged from four to 52 weeks and included one to seven exercise sessions per 
week (majority of sessions lasted 30-60 minutes). Exercise intensity ranged from 
35-95% V̇O2peak. Endurance exercise training-mediated decreases in BP 
averaged 3.5 mmHg for systolic BP and 2.5 mmHg for diastolic BP. Additionally, 
the largest reductions in BP following endurance training were significantly 
greater in hypertensive individuals compared to prehypertensive and 
normotensive individuals. These results are consistent with previous systematic 
reviews stating that structured aerobic exercise interventions of moderate 
intensity and adequate volume result in an independent reduction in resting BP of 
approximately 4-10 mmHg in systolic and 3-8 mmHg diastolic BP regardless of 
age or sex for individuals with stage 1 HTN.65, 85, 87, 88 Based in part upon this 
scientific evidence, Pescatello and colleagues published an exercise prescription 
update regarding HTN.89 This updated exercise prescription includes the 
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following to elicit the greatest BP benefit for adults with HTN: ≥30 minutes per 
day of moderate intensity aerobic exercise on most days of the week and 
dynamic resistance exercise 2-3 days per week, totaling ≥150 minutes of 
exercise per week.  
Insulin resistance 
Insulin resistance develops when the body produces insulin but does not 
use insulin efficiently to uptake glucose into cells for energy usage and storage, 
causing a buildup of glucose in the blood. This hyperglycemic state triggers the 
pancreas to increase β-cell production of insulin to try to counteract the high 
levels of blood glucose. Eventually, the β-cells can no longer meet the demands 
for insulin production caused by hyperglycemia, exacerbating the levels of 
glucose in the blood. Insulin resistance can lead to the development of Type 2 
diabetes mellitus (T2D) and CVD. As stated by the AHA, an individual with T2D 
is at approximately two to four times greater risk for dying from CVD compared to 
a non-diabetic individual.2, 90  
Several large observational cohort studies, including the Harvard Alumni 
Study91, US male physicians92, and the Nurses’ Health Study93, 94, have 
established physical activity participation as a highly effective way to avert or 
delay T2D onset, and can reduce adverse CVH outcome and mortality risk 
amongst those with T2D. In addition to general physical activity participation, 
there is a well-documented, inverse, curvilinear association between CRF and 
risk of prediabetes, T2D, and metabolic syndrome.93, 95-99 Individuals with 
moderate to high levels of CRF only have small differences in T2D risk rates 
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between each CRF level. Conversely, those with low CRF that gain small 
increments in CRF are associated with large decreases in risk for developing 
T2D, highlighting the importance of physical activity and exercise interventions 
targeting individuals who are the least fit and stand the most to gain from 
improved CRF.47  
In the human body, skeletal muscle is the largest consumer of glucose. 
Not only does insulin stimulate uptake of glucose into muscle cells, but these 
cells also have glucose transporter proteins, GLUT-4 specifically, that instigate 
glucose uptake. Exercise increases glucose uptake into working muscle cells via 
the GLUT-4 transporter in an insulin-independent manner.100 A strong evidence 
base exists with numerous exercise training studies supporting the idea that both 
aerobic and anaerobic exercise training can improve both glucose uptake and 
insulin sensitivity, making exercise a remarkable modulator for T2D and CVD 
risk.101, 102  
The seminal study by the Diabetes Prevention Program study provided 
strong evidence that lifestyle modifications including diet and exercise were more 
effective than pharmaceutical treatment using metformin in reducing the 
incidence of T2D.103 Participants (n=3,234) were nondiabetic and had elevated 
fasting and post-load plasma glucose concentrations. Participants were 
randomized to one of three groups: placebo, metformin (850 mg twice daily), or a 
lifestyle modification group. Participants in the lifestyle intervention group were 
encouraged to achieve goals of 7% weight loss and ≥150 minutes per week of 
physical activity. After an average follow-up time of 2.8 years, the lifestyle 
!
33 
intervention reduced T2D incidence by 58%, which was significantly greater than 
the 31% reduction in the metformin group. This study stated that in order to 
prevent a single case of T2D during a three-year period, 6.9 individuals would 
have to participate in the lifestyle intervention, while 13.9 individuals would have 
to receive metformin.  
In 2014, Conn and colleagues were the first to publish a comprehensive 
meta-analysis regarding the effects of supervised exercise training on insulin 
sensitivity in healthy adults.104 This analysis included both published and 
unpublished exercise intervention studies that measured insulin sensitivity, and 
included 78 study reports and a total of 2,509 men and women. Unfortunately, 
only 68 of the reports provided adequate details of the exercise intervention. Of 
those reported, the median of the average exercise session time during 
supervised training was 51 minutes; the median of average session frequency 
was three per week; and the median of mean total number of exercise sessions 
was 51. Overall, this review documented moderate improvements in insulin 
sensitivity in healthy adults following supervised exercise interventions (mean 
effect size 0.38 and 0.43).  
Recently, Bird and Hawley reviewed the literature regarding the effects of 
physical activity and exercise on insulin sensitivity to provide an update on the 
latest research published between 2013 and 2016.105 In addition to furthering the 
support of physical activity’s beneficial association with insulin sensitivity, the 
authors summarized the following new findings: aerobic exercise may increase 
insulin sensitivity without a detectable increase in V̇O2max, a dose effect is 
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emerging that shows increases in both exercise volume and intensity modulate 
insulin sensitivity, aerobic exercise combined with resistance exercise may be 
the most effective approach compared to either exercise mode alone, and 
exercise induced benefits in insulin sensitivity may be augmented by appropriate 
dietary changes.  
Dyslipidemia 
Another major risk factor for CVD is dyslipidemia, a condition in which 
plasma cholesterol, TG, or both are elevated. Dyslipidemia can include both low 
levels of HDL-C; (HDL particles remove cholesterol from arteries) and high levels 
of LDL-C (LDL particles increase fatty deposits in arteries), which leads to 
increased risk of plaque buildup and blockages. Prevalence of lipid abnormalities 
in the United States estimated from the 2003-2006 National Health and Nutrition 
Examination Survey (NHANES) are as follows: 53% of U.S. adults have lipid 
abnormalities; 27% have high LDL-C; 23% have low HDL-C; and 30% have high 
TG. In a previous epidemiological study from 2000, low levels of HDL-C and 
elevated total cholesterol to HDL-C ratios were independently associated with 
risk for coronary artery disease (CAD). For every 1 mg/dL increase in HDL-C, 
there was a 2% decreased risk for CAD in men and a 3% reduction in risk for 
women.106  
In 2015, Sarzynski et al.107 examined the associations of baseline CRF 
and changes in CRF on incident dyslipidemias in participants from the CARDIA 
study (n=4,898). Over a 25-yr follow-up period, a significant inverse relationship 
was found between the 25-yr incidence rate for each dyslipidemic trait (low HDL-
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C, high TG, and high LDL-C) and baseline CRF. For example, the 25-yr incident 
rate for high TG was 42% lower in the highest CRF quartile at baseline compared 
to the lowest CRF quartile. For each of these dyslipidemic traits, those in the 
highest sex-specific CRF quartile at baseline had significantly lower incidence 
rates than the other three CRF quartiles. For each additional stage completed 
during maximal fitness testing (two min per stage), risk for incident low HDL-C, 
high TG, and high LDL-C was decreased by 9%, 16%, and 14%, respectively. 
When evaluating the influence of sex and race, the association of baseline CRF 
with 25-yr incidence of high TG appeared to be limited to white participants only. 
There were no significant associations found in black participants. Longitudinal 
results from adjusted regression models were not significant for the prediction of 
5-yr incidence of dyslipidemias based on 20-yr change in CRF. On the other 
hand, baseline CRF did significantly predict 5-yr incidence of high TG.107 The 
results from this study support the notion that achieving higher levels of CRF are 
related to decreased risk for incidence of dyslipidemias, particularly high TG.  
A recent report looked at the impact of both baseline CRF and changes in 
CRF on the risk for developing atherogenic dyslipidemia in men and women from 
the ACLS.108 Atherogenic dyslipidemia was defined by the following: low HDL-C 
(<40 mg/dL), high LDL-C (≥160 mg/dL), and high TG (≥200 mg/dL). A total of 
9,651 participants were followed over an average of 8.9 years. During follow-up, 
193 participants developed atherogenic dyslipidemia. Participants with high 
levels of CRF at baseline had 43% lower odds of developing atherogenic 
dyslipidemia compared to low fit individuals. However, once baseline HDL-C, 
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LDL-C, and TG were accounted for in the analysis, this association became 
nonsignificant. When looking at changes in CRF over time, participants who 
maintained their fitness level had 43% lower odds of developing atherogenic 
dyslipidemia compared to those who had a reduction in CRF level. This 
relationship remained statistically significant after additional adjustment for 
baseline lipid metrics.108 Therefore, this study demonstrated a protective effect of 
CRF against the risk for developing atherogenic dyslipidemia.  
The majority of epidemiological and clinical evidence supports the 
following concept: when adequate intensity, duration, and volume of aerobic 
exercise are performed by both healthy individuals and those with dyslipidemia, 
there are favorable and independent alterations in blood lipids and lipoproteins.88, 
109-111 Mounting evidence exists suggesting that the magnitude of changes in 
HDL-C is related more to the volume of exercise rather than the intensity.109, 110, 
112 To achieve significant changes in HDL-C, volume of exercise needed is 
estimated to be 1,000 to 1,500 kcal/week.113,88 
When looking at the components of dyslipidemia, the evidence describing 
increases in HDL-C with exercise is more consistent in comparison to the 
evidence describing reductions in total cholesterol, LDL-C, and TG 
concentrations.111, 112, 114 LDL-C is largely unaffected by regular exercise when 
body weight and diet remain unchanged.114-116 When exercise is combined with 
alterations in diet in patients with dyslipidemia, LDL-C reductions can be greater 
compared to reductions achieved by diet or exercise alone.117 Furthermore, 
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exercise training has been shown to attenuate reductions in HDL-C that typically 
result from low-fat diets.117-120  
Kodama and colleagues performed a meta-analysis investigating the 
effects of aerobic exercise training studies on HDL-C.121 Twenty-five aerobic 
training randomized controlled trials were included for review. Average 
intervention duration was 27 weeks with a mean frequency of 3.7 sessions per 
week, mean session time of 40.5 minutes, mean estimated energy expenditure 
was 1,019 kcal/week, and mean absolute and relative intensity was 64.8% 
V̇O2max and 5.3 METs, respectively. Overall, the exercise interventions produced 
a modest, yet highly significant beneficial change in HDL-C of 2.53 mg/dL. This 
analysis estimated a minimal exercise volume threshold of 900 kcal/week or 120 
minutes of total exercise per week to induce a significant elevation in HDL-C. In 
addition, each 10-minute increase in exercise duration corresponded to 
approximately a 1.4 mg/dL elevation in HDL-C. Finally, exercise training was 
found to be more effective in participants with lower body mass index or higher 
baseline HDL-C levels.  
Overweight and obesity 
According to the World Health Organization (WHO), overweight (OW) and 
obesity (OB) are classified by the following: OW is a body mass index (BMI) 
between 25.0-29.9 kg/m2 and OB is a BMI greater than or equal to 30 kg/m2. 
Based upon NHANES data from 2009-2012, 69% of U.S. adults are OW and 
35% are considered OB.122 As documented by numerous reports, there is a 
strong association between OW/OB and increased prevalence of CVD, making 
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OW and OB well-established CVD risk factors.122-128 In addition, excess risk 
results from OW and OB coexisting with several other major CVD risk factors, 
like HTN, atherosclerosis, metabolic syndrome, dyslipidemia, T2D, and 
obstructive sleep apnea.129 Increased adiposity, especially visceral adiposity, has 
also been shown to independently provoke alterations in cardiac structure and 
function, further compounding the effects of OB on CVD risk.129, 130  
Both central and peripheral hemodynamics are altered by weight gain and 
OB that predispose individuals to ventricular dysfunction and heart failure, 
including increased central and total blood volume, decreased systemic vascular 
resistance, and increased left ventricular (LV) stroke volume and filling 
pressures, cardiac output, and pulmonary artery pressures.130-133 OB increases 
the likelihood of having LV remodeling, left atrial enlargement, increased right 
ventricular mass, and greater end-diastolic volume.134-137 Moreover, OB is 
associated with LV diastolic dysfunction, subclinical LV systolic dysfunction, and 
reduced right ventricular ejection fraction. 132, 138-141 
Although a strong association between excess adiposity and CVD risk 
exists, the evidence base demonstrating a phenomenon termed the “obesity 
paradox” has grown. Recent evidence from Lavie and colleagues has shown a 
better prognosis in patients with CVD who are OW and mildly OB compared to 
patients with CVD who are leaner. Patients with CVD who are underweight 
usually display the worst outcomes.131, 132 Currently, the mechanisms by which 
this phenomenon relates to CVD outcomes are poorly understood.129 Although 
this topic is beyond the scope of this review, this growing area of research 
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suggests that muscle mass, strength, and CRF are major prognostic 
determinants in OB patients with CVD (specifically coronary artery disease and 
heart failure) and is important to note.142-145 
A complex interaction exists between adiposity and CRF in regards to 
CVD risk and mortality, referred to as the “fit and fat” phenomenon, where high 
levels of CRF largely negate the adverse health effects of body fatness and 
additional CVD risk factors like OW/OB, T2D, and HTN.146-155 Two landmark 
fitness-fatness studies arose from the ACLS in 1999.154, 155 Both of these studies 
analyzed data from over 21,000 men with approximately 8-10 years of follow-up 
from the ACLS and found that low CRF was strongly, independently, and 
inversely associated with CVD and all-cause mortality, regardless of body 
fatness.  These pivotal studies concluded that OB did not appear to increase 
mortality risk in fit men, and that low CRF is as important as T2D, HTN, high 
cholesterol, and smoking as a predictor of CVD and all-cause mortality in OW 
and OB men. Since then, these findings have remained consistent amongst 
additional ACLS reports in both men and women.156 For example, in 14,345 men 
from the ACLS, Lee and colleagues found that each 1-MET increase in CRF 
between two maximal exercise tests that were on average 6.3 years apart was 
associated with a 15% reduction in all-cause mortality and a 19% reduction in 
CVD mortality (results were after adjustment for potential confounders and 
changes in CRF).157 Change in BMI was not associated with CVD or all-cause 
mortality after adjustment for potential confounders and CRF change. 
!
40 
Additionally, men who lost fitness had higher risks of all-cause and CVD mortality 
regardless of change in BMI.  
There are several factors that appear to play a role in the alteration of 
CVD risk due to increases in exercise and CRF in OW/OB patients, such as body 
composition, insulin resistance, endothelial dysfunction, oxidative stress, platelet 
reactivity, and inflammation.129 As visceral adiposity is a strong predictor of 
CVD,158 one example of CRF-mediated changes in CVD risk is the ability of 
exercise training to influence the distribution of body fat.36, 159-162 In 2013, Vissers 
et al. conducted a meta-analysis of 15 exercise training studies without 
hypocaloric diet on the effects of exercise on visceral adipose tissue (VAT) in 
OW adults.162 This study analyzed data from 9 controlled and 6 uncontrolled 
exercise trials (n=852), including aerobic, strength, or combined aerobic and 
strength training interventions, that had measures of VAT from computed 
tomography (CT) scan or magnetic resonance imaging (MRI). Overall, this meta-
analysis found that aerobic training of moderate or high intensity had the greatest 
effect for reducing VAT in men and women compared to low intensity aerobic or 
strength training. This study found that after just 12 weeks of intervention, 
aerobic exercise training could beneficially reduce VAT (as measured by CT 
analysis) by more than 30 cm2 in women and 40 cm2 in men. Thus, this study 
concluded that decreases in VAT can be achieved via moderate and high 
intensity aerobic exercise without hypocaloric diet in OW/OB individuals, which 
beneficially effects CVD risk.162 
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CHAPTER 4 
THE ASSOCIATION OF CARDIORESPIRATORY FITNESS AND 
IDEAL CARDIOVASCULAR HEALTH IN THE AEROBICS CENTER 
LONGITUDINAL STUDY 
INTRODUCTION 
In 2010, the American Heart Association (AHA) established a new 
construct as part of the 2020 Impact Goals called ideal cardiovascular health 
(CVH), which is characterized by seven metrics known as Life’s Simple 7 (LS7).3 
The LS7 concept emphasizes seven positive health factors [blood cholesterol, 
blood pressure (BP), and fasting plasma glucose] and behaviors [diet quality, 
physical activity (PA), smoking, and body mass index (BMI)]. Each of the seven 
components is classified into ideal, intermediate, or poor categories and an ideal 
CVH score is created. A previous study from the Aerobics Center Longitudinal 
Study (ACLS) showed that ideal CVH was associated with risk of cardiovascular 
disease (CVD) mortality as demonstrated by an inverse, graded CVD mortality 
risk in relation to the number of ideal metrics met.163 In addition, several cross-
sectional and prospective cohort studies have found that increasing numbers of 




Cardiorespiratory fitness (CRF) is well established as having a strong 
association with mortality and numerous CVD risk factors.1 Despite the strong 
associations between CRF and each individual component of LS7, few studies 
have examined the independent association of CRF and ideal CVH score. 
Recently, Ruiz et al. found that CRF was positively associated with ideal CVH 
score in European adolescents (N=510) and identified a theoretical CRF 
threshold associated with a more favorable CVH profile.164 However, to our 
knowledge no study has examined the association between CRF and ideal CVH 
in adults neither cross-sectionally nor longitudinally. Therefore, the purposes of 
our study were 1) to evaluate if CRF is associated with ideal CVH and 2) to 
examine the relationship between changes in CRF and changes in ideal CVH 
score over time in the ACLS cohort. 
METHODS 
Study Population 
The ACLS is a prospective observational study of participants who were 
self-, employer-, or physician-referred for an extensive medical examination at 
the Cooper Clinic in Dallas, Texas. The study investigated the health outcomes 
associated with PA and CRF.17 All participants received written and oral informed 
consent and the ACLS study has been reviewed and approved annually by the 
Cooper Institute’s Institutional Review Board. The present study included 
individuals with complete data on CRF and all of the AHA’s LS7 health behaviors 
and factors between the years of 1987-1999. Participants were excluded if they 
had any form of CVD or cancer, or if they had abnormal findings on 
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electrocardiography at baseline. The final analysis included 11,590 participants 
who were predominately white, well-educated, and upper middle class.17 
Clinical Examinations 
Participants completed at least one medical examination by a physician 
after a 12-hour overnight fast. The medical examination was a complete 
preventive medical evaluation including physical examination, personal and 
family health history, questionnaires (demographics and health habits), 
anthropometry, resting electrocardiography, blood chemistry analyses, BP, and a 
maximal exercise treadmill test. Health history questionnaires included: personal 
history of myocardial infarction, stroke, hypertension, diabetes, and cancer; 
parental history of CVD; smoking status, alcohol intake, and PA. Participants also 
completed a 3-day diet recall. Time between examinations ranged from 12 
months to 11 years. Details of the examinations have been described 
elsewhere.17  
Measurements. Anthropometric measures were taken and BMI was 
calculated as weight in kilograms divided by height in meters squared and 
classified as follows: normal (18.5-24.9 kg/m2), overweight (25.0-29.9 kg/m2), or 
obese (≥30.0 kg/m2). Resting BP was taken following AHA protocol.17 To ensure 
accuracy, two measures were taken and if the readings differed by more than 5 
mmHg, then a third measure was taken and all the measures were averaged. 
Concentrations of total cholesterol and fasting plasma glucose were measured 
by automated techniques that followed the standards of the Centers for Disease 
Control and Prevention Lipids Standardization Program.165  
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Cardiorespiratory Fitness. Maximal treadmill testing using a modified 
Balke protocol was used to assess CRF as treadmill time in minutes at baseline 
and during follow-up visits, as previously described.17, 21 Three CRF groups were 
created from age- and sex-specific quintiles based on the previously established 
cutpoints of treadmill time: low (bottom 20%), moderate (middle 50%), and high 
(top 20%) CRF.17 Change in CRF as a continuous variable was calculated as the 
difference in treadmill time between the first two successive examinations and 
divided by the number of years between them. Annual change in CRF was used 
to define change in fitness because the intervals between the follow-up 
examinations varied among individuals in ACLS. Change in CRF was 
categorized by grouping participants into categories of loss, stable, or gain, 
based on tertiles of change in CRF. For example, a participant categorized in the 
low CRF group at baseline that increased to the moderate CRF group at follow-
up would be categorized in the gain group for CRF change. 
Diet. Participants were asked to keep detailed records of everything they 
consumed over two pre-assigned weekdays and one weekend day for the 3-day 
dietary assessment. Written instructions on how to accurately describe foods and 
portion sizes were given to each participant. Registered dietitians at the Cooper 
Clinic coded and analyzed the diet records using the Cooper Clinic Nutrition and 
Exercise Evaluation system. Achievement of the AHA diet goals was categorized 
as follows: 4.5 or more servings of fruits and vegetables per day, two or more 3.5 
oz. servings per week of fish, shellfish, or other seafood, three or more servings 
per day of whole grains, and less than 1500 mg per day of sodium. Diet scores 
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were assigned by giving a point for each diet goal met (i.e., consuming <1500 
mg/day of sodium is one point) for a total possible score of four points.  
Physical Activity. Participants completed a formerly validated 
questionnaire to assess leisure time PA over the past three months, which 
included type, frequency, and duration of activity. PA categories were created 
based on the responses for 10 specific activities: walking, jogging, running, 
treadmill exercise, cycling, stationary cycling, swimming, racquet sports, aerobic 
dance, and other sports related activities. The intensity of the activities was 
estimated using speed-specific or activity-specific metabolic equivalent (MET) 
values from the Compendium of Physical Activities.22 MET-minutes per week 
(min/wk) were then calculated by multiplying the MET value for each activity by 
frequency and duration. Then, MET-min/wk for all activities was added together. 
Participants were classified into three categories based on the 2008 Physical 
Activity Guidelines for Americans:23 inactive (0 MET-min/wk), insufficient (1-499 
MET-min/wk), and recommended (≥500 MET-min/wk).  
AHA Ideal Cardiovascular Health. Each ideal CVH metric was classified 
as poor (0 points), intermediate (1 point), or ideal (2 points) as described in Table 
4.1. The ideal CVH score was calculated on a 14-point scale and categorized as 
follows: inadequate (0-4 points), average (5-9 points), and optimum (10-14 
points).  
Annual change in total ideal CVH score as a discrete variable was 
calculated as the difference in total ideal CVH score between the two successive 
examinations, and divided by the number of years between them. Annual change 
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in total ideal CVH score was categorized by grouping participants into categories 
of loss, stable, or gain, based on tertiles of change as described above for 
change in CRF categories.  
Statistical Analysis 
Baseline characteristics were summarized for the total population and by 
sex. Differences between sexes at baseline were determined by t-tests for 
continuous variables and chi-square tests for categorical variables. Multivariable 
general linear and logistic regression models were used to evaluate the 
association of baseline CRF with baseline ideal CVH score and to estimate the 
odds of being in the average or optimum ideal CVH categories by baseline CRF 
categories, respectively. These cross-sectional analyses controlled for age, sex, 
and year of examination. To investigate the longitudinal association between 
changes in CRF and changes in ideal CVH, we employed linear regression 
models adjusting for age, sex, and time between exam dates. Separate models 
that included CRF and ideal CVH as either continuous or categorical variables 
were used. All models were performed in the total population and stratified by 
sex (removing sex as covariate in model). Finally, we conducted sensitivity 
analyses to examine the influence of each LS7 metric on total CVH score. No 
collinearity was observed after performing analyses to examine the influence of 
CRF on each of the LS7 metrics. SAS version 9.4 was used for all statistical 






Descriptive characteristics of the study population (n=11,590) are given in 
Table 4.2. The study population had a mean (standard deviation) age of 45.8 
(9.8) years and BMI of 25.8 (4.1) kg/m2. Males had higher baseline values for 
BMI, BP, total cholesterol, fasting plasma glucose, and treadmill time compared 
to females (p<0.0001). As shown in Table 4.3, the prevalence of participants 
from the total sample meeting ideal levels for each CVH metric at baseline was 
(in ascending order): healthy diet 4.3% (n=497), BP 33.0% (n=3,827), total 
cholesterol 45.9% (5,314), BMI 47.2% (n=5,473), smoking 56.2% (n=6,515), PA 
59.9% (n=6,938), and fasting plasma glucose 61.9% (7,171). Only 0.24% of the 
total sample met ideal levels for all seven metrics at baseline. 
Cross-sectional association of CRF and ideal CVH. Treadmill time was 
moderately correlated (p<0.0001) with CVH score in both males (r=0.56) and 
females (r=0.50). The prevalence of inadequate, average, and optimum 
categories for CVH score by baseline CRF category is displayed in Figure 4.1. 
For those in the low fitness group, only 10.8% were in the optimum category for 
ideal CVH score, while 17.1% were in the poor category. Conversely, only 0.4% 
of the high fit participants were in the poor category, while 54.2% achieved an 
optimum ideal CVH score.  
In multivariable regression models, baseline treadmill time, sex, and age 
explained 15.2%, 14.3%, and 0.82% of the variance in total CVH score at 
baseline (all p<0.0001), respectively. After adjusting for age, sex, and year of 
examination, participants in the optimum CVH category had 20% and 43% higher 
!
48 
CRF levels than those in the average and inadequate CVH groups (p<0.0001), 
respectively (Figure 4.2). The adjusted odds [shown as odds ratio (95% 
confidence interval] of being in the average or optimum ideal CVH category were 
10.9 (7.9-14.9) and 39.9 (28.7-55.4) times greater for individuals with moderate 
and high CRF, respectively, compared to those with low CRF (p<0.0001) (Figure 
4.3). 
Longitudinal association of CRF and ideal CVH. The association 
between change in fitness and change in ideal CVH score was examined in 
2,555 adults who had at least two clinic visits. After a mean follow up of 3.3 ± 2.4 
years, the average change in ideal CVH score per year was 3.9 ± 20.9% and the 
average change in treadmill time per year was 1.2 ± 9.2% for the total sample. 
Annual change in ideal CVH score and annual change in treadmill time were 
positively correlated (p<0.0001) in both males (r = 0.40) and females (r = 0.26). 
After controlling for age, sex, and time between exam dates, the gain in 
fitness group (n=851) significantly (p<0.0001) increased their ideal CVH score by 
13.9 ± 1.1%, while the loss of fitness group (n=873) significantly (p<0.0001) 
decreased their score by 4.5 ± 1.1% (Figure 4.4). Baseline ideal CVH score and 
annual change in treadmill time explained 18.5% and 9.0% of the annual change 
in ideal CVH score, respectively, while changes in diet, cholesterol, smoking, 
diastolic BP, PA, glucose, BMI, and systolic BP explained 7.5%, 4.9%, 2.8%, 
2.2%, 1.5%, 1.5%, 0.8%, and 0.4%, respectively (p<0.0001 for all variables). For 
every minute increase in treadmill time per year, annual ideal CVH score 




 This study is likely the first to examine both cross-sectional and 
longitudinal associations of CRF with ideal CVH, as defined by the AHA’s LS7, in 
middle-aged men and women. One of the main findings was that higher levels of 
CRF are strongly associated with better CVH profiles, which is demonstrated by 
moderate and high fit individuals having almost 11 and 40 times greater odds of 
having average or optimum CVH, respectively, compared to low fit individuals. In 
addition, our longitudinal analyses showed that improvements in CRF over time 
are independently associated with concomitant increases in CVH scores and 
these increases in CRF explained a greater amount of variance in CVH score 
compared to each of the individual LS7 metrics (blood cholesterol, fasting plasma 
glucose, BP, smoking, BMI, diet quality, and PA).  
To date, the only study investigating the association between CRF and 
ideal CVH was completed in European adolescents aged 12.5-17.5 years 
enrolled in the Healthy Lifestyle in Europe by Nutrition in Adolescence (HELENA) 
study.164 In this study, CRF was estimated via the 20m shuttle run test. The 
results from this study complement our findings in adults, as higher CRF levels 
were associated with a higher number of LS7 metrics at ideal levels in 
adolescents. CRF levels were significantly higher in both boys and girls that met 
at least four LS7 metrics at ideal levels. The results from the HELENA study and 
the present ACLS study show promising associations between CRF level and 
ideal CVH score in both adolescents and adults, thus warranting further 
investigation in differing populations.   
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In 2012, Yang et al. examined ideal CVH prevalence trends across the 
National Health and Nutrition Examination Survey (NHANES) in adult men and 
women from 1988 to 2010.13 The study found that the prevalence of meeting all 
LS7 metrics at ideal levels was low (only 1.2% in NHANES 2005-2010) and that 
ideal BMI and fasting plasma glucose levels continued to decline during the study 
period. The authors reported that the all-cause and CVD mortality benefits from 
improved smoking and PA metrics were counteracted by the low prevalence of 
BMI, diet, and plasma glucose at ideal conditions. As a moderator for these 
traditional CVD risk factors, CRF has been shown to beneficially alter the 
inhibitory effects of poor levels of the LS7 metrics on all-cause and CVD 
mortality.17, 50, 51 Our study found that having moderate to high levels of CRF 
greatly decreased the odds of having an inadequate CVH score. The importance 
of this prominent relationship is highlighted when examining the association 
between ideal CVH score and mortality risk. In NHANES, as the number of ideal 
LS7 metrics met increased, all-cause, CVD, and ischemic heart disease mortality 
rates significantly decreased.13 Therefore, even having a moderate level of CRF 
decreases the odds of having an inadequate CVH score, which in turn is likely 
related to decreased mortality rates. Thus, as mounting evidence strongly 
supports the benefits of high levels of CRF and PA on CVD risk factors and 
mortality,1 our findings emphasize the potential importance of lifestyle 
interventions that include exercise/PA to improve both CRF and CVH status, 
strengthening the AHA’s ideal CVH primordial prevention approach.   
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 The present analyses benefited from several strengths of the ACLS study 
design. The ACLS cohort includes a relatively large number of participants 
enrolled in a prospective study with extensive follow-up. Participants underwent 
thorough medical examinations and maximal exercise tests, providing several 
valid, objective measures for some of the LS7 metrics and CRF at both baseline 
and follow-up (average time between exam dates was 3.3 years). We also 
excluded participants at baseline who had a history of CVD or cancer, who had a 
BMI <18.5 kg/m2, or who had abnormalities on electrocardiography, which 
reduced the likelihood of including participants who had underlying subclinical 
disease. Our study also has limitations to consider. The use of the AHA’s ideal 
CVH construct to create the CVH score assumes that all LS7 health factors and 
behaviors equally contribute to the final score. To determine the relationship 
between CRF and ideal CVH score, CRF was entered into the model 
independently, but we acknowledge that each of the LS7 metrics have been 
found to be associated with CRF. However, our analyses did not demonstrate 
collinearity between CRF and the LS7 metrics. Additionally, the diet quality and 
PA LS7 metrics in our study relied on self-report data, which can introduce 
biases. The instruments and procedures utilized were standardized and validated 
in order to minimize the effect of bias. Furthermore, compared with the AHA 
definition of ideal CVH, we made minor adjustments to assessing diet quality, 
smoking status, and medication use. There was insufficient information to include 
sugar-sweetened beverages in assessing diet components, as well as lack of 




Our study found that higher levels of CRF are associated with better CVH 
profiles in both men and women. In addition, improving CRF during middle age 
was independently associated with higher CVH scores and greater improvement 
in CVH. Our findings support future research regarding the use of exercise 
interventions as a primordial prevention to not only improve CRF, but also to 
improve and maintain ideal CVH to achieve the AHA 2020 Impact Goals and 
reduce the burden of CVD in America.  
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Table 4.1. Definition of poor, intermediate, and ideal levels for each 
cardiovascular health metrica  
Cardiovascular Health Metric Poor (0) Intermediate (1) Ideal (2) 
Smoking Current Former Never 
Body mass index (kg/m2) ≤30 25-29.9 18.5-24.9 
Physical activity (MET-min/week) 0 1-499 ≥500 
Healthy diet score (No. of 
components) 
0-1 2 3-4 
Total cholesterol (mg/dL) ≥240 200-239 <200 
Blood pressure (mmHg) 
SBP ≥140 or       
DBP ≥90 
SBP 120-139 or            
DBP 80-89 
SBP <120 and           
DBP <80 
Fasting plasma glucose (mg/dL) ≥126 100-125 <100 
MET: metabolic equivalent; SBP: systolic blood pressure; DBP: diastolic blood 
pressure 
a SI conversion factors: to convert total cholesterol values from mg/dL to mmol/L, 
multiply by 0.0259; to convert fasting plasma glucose values from mg/dL to 
mmol/L, multiply by 0.0555 
b Plus no previous physician diagnosis of hypercholesterolemia 
c Plus no previous physician diagnosis of hypertension 
d Plus no previous physician diagnosis of diabetes or use of insulin 
 
Table 4.2. Baseline characteristics by sex  





Age (years) 45.8 (9.8) 46.2 (9.7) 44.8 (10.0) 
Body mass index (kg/m2) 25.8 (4.1)  26.5 (3.7) 23.5 (4.4) 
Systolic blood pressure (mmHg) 119.4 (13.9) 121.6 (13.1) 112.1 (13.8) 
Diastolic blood pressure (mmHg) 80.1 (9.8) 81.5 (9.4) 75.4 (9.4) 
Total cholesterol (mg/dL) 206.6 (39.9) 208.6 (40.0) 199.7 (39.2) 
Fasting plasma glucose (mg/dL) 98.8 (16.1) 100.1 (15.5) 94.7 (17.2) 
Treadmill time (min) 18.1 (5.2) 19.2 (4.9)  14.5 (4.6) 
Data presented as mean (SD) 
P-value for difference between sexes < 0.0001 for all variables 
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Table 4.3. Prevalence of participants meeting ideal levels for each 
cardiovascular health metric at baseline in the total population and by sex  
Cardiovascular health 







Smoking* 56.2 53.5 65.0 
Body mass index*  47.2 38.7 75.1 
Physical activity 59.9 59.7 60.4 
Diet* 4.3 4.6 3.4 
Total cholesterol* 45.9 43.3 54.3 
Blood pressure* 33.0 25.8 56.4 
Fasting plasma glucose* 61.9 56.9 78.0 
All seven metrics at ideal 
level 
0.24 0.17 0.48 
Data presented as percentage  
*Significantly different between sexes (p< 0.0001) 
 



















In a d e q u a te  (0 -4 )
A v e ra g e  (5 -9 )









Figure 4.1. Prevalence of inadequate, average, and optimum scores for 




Figure 4.2. Average treadmill time in the total population and by sex based on 
ideal cardiovascular health category. Values adjusted for age and year of 












































































Figure 4.3. Adjusted odds of being in the average or higher ideal cardiovascular 
health category by baseline fitness category. Values adjusted for age and year of 
examination. p<0.0001 for all group and sex comparisons. 
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Figure 4.4. Percent change in ideal cardiovascular health score by change in 
fitness group. Values adjusted for age, sex, and time between exam dates. 
*p<0.0001 for difference with all other groups 
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CHAPTER 5 
CARDIORESPIRATORY FITNESS AND CARDIOMETABOLIC 
DISEASE RISK FACTOR RESPONSIVENESS FOLLOWING 
AEROBIC EXERCISE INTERVENTION 
INTRODUCTION 
Cardiorespiratory fitness (CRF) is well established as having a strong 
inverse association with numerous cardiometabolic disease risk factors and 
cardiovascular disease (CVD) mortality.1 As CVD remains the number one cause 
of death in America,2 the detrimental effects of low CRF present a substantial 
health threat. In order to help combat these detrimental effects, aerobic exercise 
interventions are used to increase CRF, as measured by maximal oxygen uptake 
(V̇O2max), and improve cardiometabolic risk factor profile. However, considerable 
inter-individual variation exists in the ability to improve V̇O2max and 
cardiometabolic risk factors in response to regular exercise.166-172 Thus, 
identifying individuals who do not experience significant gains in CRF with 
aerobic training (i.e., low V̇O2max response) and how low V̇O2max response relates 
to risk factor responsiveness is of great interest. As we move further into the era 
of personalized medicine, a better understanding of the inter-individual variation 





medicine and provide appropriate guidance to improve health and attenuate CVD 
risk. 
The HEalth, RIsk factors, exercise Training And GEnetics (HERITAGE) 
family study has been instrumental in the development of the strong body of 
evidence supporting the presence of heterogeneous V̇O2max and cardiometabolic 
risk factor responsiveness to exercise training.166-168, 173, 174 Although several 
exercise training studies have reported the distribution of V̇O2max responsiveness 
to standardized exercise interventions,166, 169, 171, 172, 174-180 the prevalence of 
individuals experiencing low V̇O2max responsiveness remains unknown as there is 
currently no widely accepted threshold to define V̇O2max responsiveness. Thus, 
the goal of the present study was to establish cutpoints to identify low V̇O2max 
response and examine the prevalence of low V̇O2max response across several 
diverse exercise interventions. We also sought to examine the relationship 
between V̇O2max responsiveness and exercise-induced changes in 
cardiometabolic risk factors.  
METHODS 
The effects of standardized, supervised aerobic exercise training on 
V̇O2max and cardiometabolic risk factor responsiveness was examined across 
eight exercise training studies comprised of 14 distinct exercise interventions. 
The studies are briefly described below, followed by the definitions of low 
response for each trait and the statistical procedures employed. Overall, the 
exercise interventions from these studies ranged from doses of 4-35 kcal·kg-





Study-specific exercise intervention information is shown in Table 5.1. Data on a 
maximum of 1,724 adults who completed one of the 14 exercise interventions 
were available for analysis.  
Exercise Training Studies 
Dose-Response to Exercise in Women (DREW) study. The DREW 
Study was a randomized controlled dose-response exercise trial. A complete 
description of the design, methods, and study participants has been published.24, 
173 The present cohort included 361 previously sedentary, post-menopausal, 
overweight or obese women (63% White) with high-normal blood pressure who 
completed one of three 24-week aerobic exercise interventions. The three 
exercise interventionss were designed for participants to expend 4 (n=155), 8 
(n=104), or 12 (n=102) KKW. All participants alternated training sessions on a 
cycle ergometer or treadmill with a target intensity of 50% V̇O2max. Exercise 
training sessions were completed three to four times per week.  
Gene Exercise Research Study (GERS). The GERS cohort included 171 
previously sedentary, non-diabetic, non-smoking men and women (56%) aged 
50-71 years (73% White). Participants had no history of CVD, had a BMI <37 
kg/m2, and were either normotensive or had medication-controlled hypertension. 
The exercise intervention consisted of 24 weeks (three sessions per week) of 
aerobic exercise. Training progressed to a target exercise intensity of 70% 
V̇O2max.26, 27 Participants used various types of aerobic exercise equipment 






HERITAGE Family Study. The HERITAGE cohort included 718 (66% 
White) men and women (56%) aged 17-65 years who completed a 20-week 
aerobic exercise intervention. Participants were previously sedentary, 
normotensive to untreated mildly hypertensive, and had a body mass index (BMI) 
<40.0 kg/m2. The intervention consisted of aerobic exercise performed three 
days per week on a cycle ergometer. Training progressed to a target exercise 
intensity of 75% V̇O2max.28  
Energy Flux study. The Energy Flux Study was a randomized controlled 
exercise trial that included 64 men and women (45%) aged 21-45 years (48% 
White) who completed one of two 24-week aerobic exercise interventions. 
Participants were previously sedentary, generally healthy adults with a BMI of 25-
35 kg/m2. The two exercise interventions were designed for participants to 
expend 17.5 (n=33) or 35 (n=31) KKW. Training progressed to a target exercise 
intensity of 70-75% maximal heart rate. One month and three months into the 
intervention, participants performed additional maximal exercise tests. Exercise 
intensity was adjusted throughout the intervention based on the most recent 
maximal exercise test. All exercise was performed on a treadmill 3-6 times per 
week. 
Inflammation and Exercise (INFLAME) study. The INFLAME cohort 
included 66 previously sedentary, generally healthy, non-smoking men and 
women (65%) with elevated plasma C-Reactive Protein concentration (≥2.0 mg/L 
but <10.0 mg/L) who completed a 16-week aerobic exercise intervention. At 





kg/m2, and blood pressure <140/90 mmHg. The exercise intervention was 
designed for participants to expend 16 KKW at a target exercise intensity 60-80% 
V̇O2max. Exercise was performed on either a treadmill or cycle ergometer 3-5 
times per week.29 
Examination of Mechanisms of Exercise-induced Weight 
Compensation (E-MECHANIC) study. E-MECHANIC was a six-month 
randomized controlled exercise trial, which included 117 men and women (72%) 
who completed one of two aerobic exercise interventions. Participants (68% 
White) were non-smoking, generally healthy, previously sedentary adults (aged 
18-65 years) with a BMI of 25-45 kg/m2. The two exercise interventions were 
designed for participants to expend 8 (n=60) or 20 (n=57) KKW for 24 weeks. All 
exercise was performed on a treadmill at a target intensity of 65-85% V̇O2max. 
Exercise sessions were completed 3-5 times per week.30 
Studies of a Targeted Risk Reduction Intervention through Defined 
Exercise (STRRIDE). The STRRIDE I31 and II32 studies were randomized 
exercise trials. The present cohort included 227 (83% White) non-smoking men 
and women (50%) who completed eight months of exercise training. Participants 
were free of diabetes and coronary artery disease, aged 40-65 years with a BMI 
25-35 kg/m2, resting blood pressure <160/90 mmHg, and mild-to-moderate 
dyslipidemia [low-density lipoprotein cholesterol (LDL-C) 130-190 mg/dL and/or 
high-density lipoprotein cholesterol (HDL-C) 40mg/dL (men) or 45 mg/dL 
(women)]. Combining STRRIDE I and II, participants completed one of four 





KKW; 65-80% V̇O2peak; n=90), high (23 KKW; 65-80% V̇O2peak; n=57), or 
moderate plus resistance training (three days per week, three sets per day, and 
8-12 repetitions per set; n=44). Aerobic exercise was performed three times per 
week on treadmills, elliptical machines, or cycle ergometers.  
Measurements of Cardiorespiratory Fitness and Cardiometabolic Risk 
Factors 
All participants underwent multiple laboratory measures at baseline and 
post-training. Full details for each of the studies are available elsewhere.24-32 
Briefly, all studies objectively measured V̇O2max with gas exchange during graded 
maximal exercise testing. Blood pressure was measured after participants sat 
quietly for at least five minutes. Blood samples were obtained from venipuncture 
of an antecubital vein in the morning following an overnight fast. Post-training 
blood samples were obtained approximately 16-72 hours after the completion of 
the final exercise session. All studies included plasma measures of HDL-C and 
triglycerides (TG) via enzymatic methods except for STRRIDE I and II, which 
assessed HDL-C and TG concentrations via nuclear magnetic resonance 
spectroscopy. Plasma fasting insulin was assessed in all studies except Energy 
Flux, E-MECHANIC, and STRRIDE II. Plasma fasting insulin was measured by 
radioimmunoassay in GERS and HERITAGE, by immunoassay in STRRIDE I, 
and by electrochemiluminescence in DREW and INFLAME. For each of these 
traits, change (Δ) was calculated as the post-training value minus the baseline 
value. Subsequently, the change values were used to determine responsiveness 





Definition of Low Responses 
In order to define low responsiveness, technical error (TE) was used to 
define the threshold values for each trait. TE is defined as the within-subject 
standard deviation (SD) from repeated measures over a given period of time, 
which takes into account the measurement error of the trait, including the 
variance among laboratories or laboratory technicians, and the normal daily 
biological variability of the trait. For this study, the definition of low response for 
each trait was based on previous findings from reproducibility studies conducted 
in HERITAGE.37-41 These studies were designed to quantify TE, coefficient of 
variation (CV), and intraclass correlation for several traits measured in 
HERITAGE. Based on the TE and CV values derived from these studies, low 
V̇O2max response was defined in both absolute (gain <120 ml/min from baseline 
value) and relative (gain < 5% of study-specific baseline average V̇O2max in 
mL·kg- 1·min-1) terms. In regards to each of the cardiometabolic risk factors, any 
value beyond 1xTE in a direction indicating a worsening of the risk factor was 
considered a low response. Accordingly, the threshold values to determine low 
response were: Δ plasma fasting insulin ≥12 pmol/L; Δ plasma HDL-C ≤0.12 
mmol/L; Δ plasma TG ≥0.21 mmol/L; and Δ resting systolic blood pressure (SBP) 
≥5 mmHg. 
Statistical Analysis 
Baseline characteristics were summarized for the total population and by 
study. Prevalence of low response for each trait was assessed on the basis of 





each of the cardiometabolic risk factors, a logistic regression was performed to 
compare the distribution of low response between V̇O2max response groups. A 
total response score for all of the cardiometabolic risk factors was calculated for 
each participant. Each risk factor classified as a low response received a score of 
one, while each risk factor not classified as a low response received a score of 
zero. Thus, a participant that displayed low responses for all risk factors would 
receive four total points for their cardiometabolic risk factor response score. A 
chi-square test was performed to compare the distribution of the total response 
score between V̇O2max response groups. The threshold for statistical significance 
was set at p<0.05. SAS version 9.4 was used for all statistical analyses. Data 
presented as mean (SD) unless otherwise specified. 
RESULTS  
The overall sample (n=1,724) was comprised of 63.6% women, 29.2% 
minorities, and broad ranges of age (17-75 years), BMI (18-45 kg/m2), and 
cardiometabolic risk factors. Study-specific baseline characteristics of the 
participants are summarized in Table 5.2.  
The majority of the exercise interventions produced significant group 
mean increases in V̇O2max (data not shown). All interventions except INFLAME 
and DREW 4, 8, and 12 KKW produced significant group mean increases in 
absolute V̇O2max (p<0.05). For relative V̇O2max, all interventions except E-
MECHANIC 8 KKW and INFLAME produced significant group mean increases 
(p<0.05). Upon evaluation of individual changes in V̇O2max using the above 





(relative; individual distribution not shown) of the total sample was considered 
low responsive for V̇O2max. Within each exercise intervention group, the 
prevalence of individuals with a low V̇O2max response varied greatly, ranging from 
7.6% (HERITAGE) to 84% (DREW 4 KKW) based on the absolute definition of 
responsiveness (Figure 5.2a). As shown in Figure 5.2b, a wide range of low 
V̇O2max response prevalence was also present based on the relative definition of 
responsiveness, from 7.4% (HERITAGE) to 68.2% (INFLAME).  
Since the threshold for relative V̇O2max responsiveness was based upon 
study-specific values, the prevalence of low V̇O2max response in relative terms 
was further explored by comparing groups within studies that employed multiple 
exercise interventions. Within the DREW study, exercise intensity and 
intervention duration were equivalent amongst the exercise groups. As exercise 
dose increased from 4 to 8 to 12 KKW, the prevalence of relative V̇O2max low 
response decreased from 53.1% to 37.1% to 30.5% (p=0.001 for difference 
between groups). Similarly, in the E-MECHANIC study relative V̇O2max low 
response prevalence was lower in the 20 KKW group (26.3%) compared to the 8 
KKW group (50%) (p=0.009). Although not statistically significant (p=0.16), the 
Energy Flux study also demonstrated an inverse relationship between relative 
V̇O2max low response prevalence and exercise dose (51.5% for the 17.5 KKW 
group and 34.4% for the 35 KKW group). All of the STRRIDE interventions were 
delivered for 35 weeks, but differed in both exercise amount and intensity. The 
prevalence of low V̇O2max response followed the same trend as described above: 





decreased (55.6% for 14 KKW at 40-55% intensity compared to 14% for 23 KKW 
at 65-80% intensity, p<0.0001 for differences between groups). These results for 
studies employing multiple exercise interventions are illustrated in Figure 5.3. 
Table 5.3a and Table 5.3b show the average change for the selected 
cardiometabolic risk factors in all exercisers combined and by V̇O2max response 
groups. Overall, fasting plasma insulin, HDL-C, TG, and resting SBP changed by 
-5.39 (25.71) pmol/L, 0.01 (0.17) mmol/L, -0.07 (0.45) mmol/L, and -0.55 (10.43) 
mmHg, respectively. There were no differences in the mean values for exercise-
induced change in the four cardiometabolic traits between absolute or relative 
V̇O2max response groups. For the combined sample, prevalence of low response 
of the cardiometabolic traits ranged from 19.6% for plasma fasting insulin to 
61.7% for plasma HDL-C. For absolute low V̇O2max responders, the prevalence of 
low response was 7.5%, 22.9%, 8.1%, and 10.1% for plasma fasting insulin, 
HDL-C, TG, and resting SBP, respectively (Table 5.3a). Evaluation of low risk 
factor response on the basis of relative terms for low V̇O2max response resulted in 
lower prevalence values: 5.1%, 16.3%, 5.3%, and 7.6% for plasma fasting 
insulin, HDL-C, TG, and resting SBP, respectively (Table 5.3b). Figures 5.4a, 
5.4b, 5.4c, and 5.4d illustrate the prevalence of low response for fasting plasma 
insulin, HDL-C, TG, and resting SBP, respectively, by relative V̇O2max response 
groups in the combined sample. The prevalence of low response for each 






A total risk factor response score was calculated for 1,081 participants 
with complete risk factor response data (i.e., baseline and post-training measures 
for all four cardiometabolic risk factors). Overall, the prevalence of scores was 
20.1%, 41.1%, 26.5%, 10.9%, and 1.5% for scores of 0, 1, 2, 3, and 4, 
respectively. Figure 5.5a illustrates the distribution of total risk factor response 
scores by absolute V̇O2max response groups (significantly different between 
groups, p<0.01), while Figure 5.5b displays the total risk factor response score 
distribution by relative V̇O2max response groups (significantly different between 
groups, p<0.01). The distribution of total risk factor response score was assessed 
amongst low V̇O2max responders (n=241). Based on absolute V̇O2max terms, the 
prevalence of scores was 12.5%, 39.4%, 33.4%, 13.6%, and 1.1% for scores of 
0, 1, 2, 3, and 4, respectively (Figure 5.6a). When assessing the distribution of 
total risk factor response score amongst relative low V̇O2max responders (n=241), 
only one participant received a score of 4, while 53.1% received a score of 1 or 
lower (Figure 5.6b).   
DISCUSSION 
This study is likely the first to evaluate the prevalence of V̇O2max low 
response across diverse populations and varying exercise interventions. This 
study found a high prevalence of V̇O2max low response across 14 diverse 
exercise interventions, which differed based on how low response was defined 
(34% relative; 24% relative). We also found that the prevalence of low response 
for the cardiometabolic risk factors following exercise training varied from 19.6% 





prevalence of low response observed across all studies, the likelihood of being a 
low responder for all traits (V̇O2max, fasting insulin, HDL-C, TG, and SBP) was 
extremely low, as only one participant out of 1,081 (0.1%) did not demonstrate 
exercise training-induced changes below the low response threshold for these 
traits. As the majority of participants demonstrated a total risk factor response 
score of 1 or lower whether they were a relative low V̇O2max responder (53.1%) or 
not (63.5%), our results reinforce the idea that regular exercise participation is 
associated with many health benefits, regardless of the presence of a detectable 
V̇O2max response.   
A recent study reported on the adverse responsiveness of cardiometabolic 
risk factors (plasma fasting insulin, plasma HDL-C, plasma TG, and resting SBP) 
to exercise training in many of the same studies included in the present report.42 
Based on reproducibility studies from HERITAGE, adverse responses were 
defined as two times the TE in a direction signifying a worsening of the risk 
factor. Similar to our study’s low response prevalence, Bouchard and 
colleagues42 found that only a small minority of participants (<1%) exhibited 
adverse responses for three or more traits. Although some participants 
experienced undesirable responses for select risk factors, their results align with 
the present study as the majority of participants do not demonstrate a worsening 
of their cardiometabolic risk factor profile.42 
The HERITAGE study demonstrated the smallest prevalence of low 
V̇O2max response, which was to be expected as both the absolute and relative 





HERITAGE reproducibility studies.37 Conversely, the DREW study demonstrated 
the highest prevalence of low V̇O2max response in absolute terms (83.9%), while 
the INFLAME study had the greatest relative V̇O2max low response prevalence 
(68.2%). Although there was not a clear trend related to exercise dose, intensity, 
or program duration when comparing low V̇O2max response across all 
interventions, a trend emerged when exploring the relative V̇O2max 
responsiveness within studies that employed multiple exercise 
interventions/doses. As demonstrated by the DREW, E-MECHANIC, Energy 
Flux, and STRRIDE studies, as exercise dose and/or intensity increased, 
prevalence of low V̇O2max response decreased. This finding is comparable to a 
study conducted by Ross and colleagues that was designed to assess the 
separate effects of exercise intensity and amount on V̇O2max responsiveness.169 
In this study, participants (n=121 middle-aged men and women) were 
randomized to one of three exercise groups: low amount and low intensity, high 
amount and low intensity, or high amount and high intensity. Results 
demonstrated that increasing either the intensity or the amount of exercise 
substantially reduced the rate of V̇O2max non-response (defined as a change 
within 1xTE). When comparing exercise groups of the same intensity, the rate of 
non-response was reduced by about half when the amount of exercise doubled. 
Furthermore, when comparing groups with a fixed amount of exercise, there was 






A recent report by Montero and Lundby further investigated this dose-
response relationship in a short-term exercise training study (n=78 young, 
healthy males).181 At the completion of a six-week exercise intervention, 
participants classified as CRF non-responders completed a successive six-week 
training program that included two additional exercise sessions per week. Non-
responses were defined as any change in CRF, determined by maximal 
incremental exercise power output, within the typical error of measurement 
(±3.96%). Upon completion of the second exercise intervention, prevalence of 
non-response was eliminated. Although the findings were limited to a sample of 
healthy young males who completed only 12 total weeks of exercise, the authors 
concluded that increasing the dose of exercise in a repeated exercise 
intervention could abolish CRF non-response.181 We do not know whether low 
responders in a different population with additional risk factors, like the present 
study includes, would improve their responsiveness if they were exposed to 
different exercise doses. However, the work by Montero and Lundby offers 
promising insight for future research in this area.  
The present study benefited from several strengths. The 14 distinct, 
randomized, and supervised exercise interventions included in this study 
provided a unique opportunity to investigate the heterogeneity of response to 
regular exercise across varying exercise interventions and a diverse population. 
The exercise interventions ranged from doses of 4-35 KKW, intensities of 50-





participants included 63.6% women, 29.2% minorities, and broad ranges of age, 
body weight, and cardiometabolic risk factors.  
We realize our approach for establishing V̇O2max low response cutpoints 
has limitations. We acknowledge that the situation becomes more complicated 
when we apply the observed TE from one study (HERITAGE) to other exercise 
interventions that differ in terms of population and exercise programming. We 
also recognize this limitation remains consistent amongst the evaluation of low 
response prevalence for each cardiometabolic risk factor. However, to calculate 
study-specific TE, performing multiple measurement visits, including maximal 
exercise tests and blood samples, at both baseline and post-intervention 
presents a substantial burden. Thus, our results underscore the need for further 
investigation to refine the process for identification of individuals who are low 
responders to exercise training.  
Conclusion 
Our study found a substantial range of individual variability that occurred 
in response to regular exercise training. This heterogeneous display of individual 
responsiveness was present for all traits across all studies. Although there was 
substantial prevalence of low response for V̇O2max, fasting insulin, HDL-C, TG, 
and resting SBP at the study level, our findings indicated that less than 1% of 
participants were low responders for all traits. Future research can aid in the 
refinement of these cutpoints to establish a suitable quantification of low 





respond unfavorably to an exercise intervention and subsequent adjustment of 





Table 5.1. Study-specific exercise intervention information 
 
 











Table 5.3a. Mean change and prevalence of low response for each 
cardiometabolic risk factor by absolute V̇O2max response group 
 
a Δ V̇O2max <120 mL/min; b Δ plasma fasting insulin ≥12 pmol/L; c Δ plasma HDL-
C ≤0.12 mmol/L; d Δ plasma triglycerides ≥0.21 mmol/L; e Δ systolic blood 
pressure ≥5 mmHg; no significant differences were found for mean changes 
between absolute V̇O2max response groups 
 
Table 5.3b. Mean change and prevalence of low response for each 
cardiometabolic risk factor by relative V̇O2max response group 
 
a Δ <5% of study-specific baseline average V̇O2max; b Δ plasma fasting insulin ≥12 
pmol/L; c Δ plasma HDL-C ≤0.12 mmol/L; d Δ plasma triglycerides ≥0.21 mmol/L; 
e Δ systolic blood pressure ≥5 mmHg; no significant differences were found for 






Figure 5.1. Distribution of absolute V̇O2max training response across studies  
 
 
Figure 5.2a. Prevalence of low V̇O2max response based on absolute terms for 







Figure 5.2b. Prevalence of low V̇O2max response based on relative terms for 
each exercise intervention ordered by increasing dose of exercise (kcal·kg-
1·week-1; KKW)  
 
 
Figure 5.3. Prevalence of low V̇O2max response based on relative terms for 
studies employing multiple exercise interventions ordered by increasing dose of 
exercise (kcal·kg-1·week-1; KKW); *indicates statistically different between 







Figure 5.4a. Prevalence of low response for plasma fasting insulin across 




Figure 5.4b. Prevalence of low response for plasma HDL-C across exercise by 







Figure 5.4c. Prevalence of low response for plasma triglycerides across studies 





Figure 5.4d. Prevalence of low response for resting systolic blood pressure 






Figure 5.5a. Distribution of risk factor response score for all exercisers (n=1,081) 




Figure 5.5b. Distribution of risk factor response score for all exercisers (n=1,081) 








Figure 5.6a. Distribution of risk factor response score amongst absolute low 




Figure 5.6b. Distribution of risk factor response score amongst relative low 





The purposes of this dissertation were to: 1) evaluate whether ideal CVH 
is associated with CRF 2) examine the relationship between changes in CRF and 
changes in ideal CVH score over time, 3) assess the prevalence of low V̇O2max 
response following aerobic exercise intervention, and 4) investigate the 
relationship between V̇O2max responsiveness and training-induced changes in 
cardiometabolic risk factors following aerobic exercise intervention.  
Methods 
The first study examined the cross-sectional relationship between CRF 
and ideal CVH score (n=11,590), as well as the longitudinal relationship between 
changes in CRF and changes in ideal CVH score over time (n=2,555) in middle-
aged men and women from the ACLS. Participants underwent thorough medical 
examination at baseline and follow-up at the Cooper Clinic in Dallas, TX. CRF 
was measured as duration in minutes from a maximal treadmill test. Ideal CVH 
score was calculated on a 14-point scale using data on LS7 metrics. Participants 
were grouped into categories of inadequate (0-4), average (5-9), and optimum 
(10-14) based on their CVH score. Three CRF groups were created based on 
previously established cutpoints of treadmill time: low, moderate, and high CRF. 
For longitudinal analyses, participants (n=2,555 who had at least two clinic visits) 
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were grouped into categories of loss, stable, or gain, by change in CRF and 
change in ideal CVH score.  
The second study investigated the responsiveness of V̇O2max and select 
cardiometabolic risk factors following aerobic exercise intervention. The 
prevalence of low V̇O2max response was examined in 1,724 previously sedentary 
adults who completed one of 14 exercise interventions. The interventions ranged 
from doses of 4-35 KKW; intensities of 50-85% V̇O2max; and durations of 20-35 
weeks. All participants underwent multiple laboratory measures at baseline and 
post-training. V̇O2max was assessed via graded maximal exercise testing with gas 
exchange. Blood pressure was measured after participants sat quietly for at least 
five minutes. Blood samples were obtained from venipuncture of an antecubital 
vein in the morning following an overnight fast. Blood samples were analyzed for 
plasma fasting insulin, HDL-C, and TG concentrations. Post-training blood 
samples were obtained approximately 16-72 hours after the completion of the 
final exercise session. For each of these traits, change (Δ) was calculated as the 
post-training value minus the baseline value.  
Low V̇O2max response was defined in both absolute (gain <120 ml/min 
from baseline value) and relative (gain <5% of study-specific baseline average 
V̇O2max in mL·kg-1·min-1) terms.. For the select cardiometabolic risk factors, any 
value beyond 1xTE in a direction indicating a worsening of the risk factor was 
considered a low response. The threshold values to assess low response were: 
Δ plasma fasting insulin ≥12 pmol/L; Δ plasma HDL-C ≤0.12 mmol/L; Δ plasma 




 One of the main findings from the first study was that higher levels of CRF 
are strongly associated with better CVH profiles, which is demonstrated by 
moderate and high fit individuals having almost 11 and 40 times greater odds of 
having average or optimum CVH, respectively, compared to low fit individuals. In 
addition, longitudinal analyses showed that improvements in CRF over time are 
independently associated with concomitant increases in CVH scores and these 
increases in CRF explained a greater amount of variance in CVH score 
compared to each of the individual LS7 metrics (blood cholesterol, fasting plasma 
glucose, BP, smoking, BMI, diet quality, and PA).  
 The second study found a high prevalence of V̇O2max low response across 
14 diverse exercise interventions, which differed based on how low response 
was defined (34% relative; 24% relative). The prevalence of low response for the 
select cardiometabolic risk factors varied from 19.6% for changes in fasting 
insulin to 61.7% for changes in HDL-C. Despite the high prevalence of low 
response observed across all studies, the likelihood of being a low responder for 
all traits (V̇O2max, fasting insulin, HDL-C, TG, and SBP) was extremely low, as 
only one participant out of 1,081 (0.1%) did not demonstrate exercise training-
induced changes below the low response threshold for these traits.  
Conclusions 
Results from this dissertation support the vital role CRF plays in public 
health efforts aiming to prevent the development of CVD and promote the 
achievement and maintenance of ideal CVH. Although substantial inter-individual 
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variation in response to regular exercise exists, results from this dissertation also 
show that regular exercise participation is associated with many health benefits, 
regardless of the presence of a detectable V̇O2max response. Future research can 
build upon these findings to refine the identification of individuals who respond 
unfavorably to regular exercise and to subsequently adjust their exercise 
prescription. This will enhance our ability to utilize exercise as medicine and 
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